<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS One</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-title-group><journal-title>PLOS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">38709790</article-id><article-id pub-id-type="pmc">11073674</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0302813</article-id><article-id pub-id-type="publisher-id">PONE-D-23-35599</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune System Proteins</subject><subj-group><subject>Immune Receptors</subject><subj-group><subject>Toll-like Receptors</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune System Proteins</subject><subj-group><subject>Immune Receptors</subject><subj-group><subject>Toll-like Receptors</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Immune System Proteins</subject><subj-group><subject>Immune Receptors</subject><subj-group><subject>Toll-like Receptors</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Cell Biology</subject><subj-group><subject>Signal Transduction</subject><subj-group><subject>Immune Receptors</subject><subj-group><subject>Toll-like Receptors</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Metastasis</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Basic Cancer Research</subject><subj-group><subject>Metastasis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancers and Neoplasms</subject><subj-group><subject>Metastatic Tumors</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Lymphatic System</subject><subj-group><subject>Lymph Nodes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Lymphatic System</subject><subj-group><subject>Lymph Nodes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Specimen Preparation and Treatment</subject><subj-group><subject>Staining</subject><subj-group><subject>Cytoplasmic Staining</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Specimen Preparation and Treatment</subject><subj-group><subject>Staining</subject><subj-group><subject>Nuclear Staining</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancers and Neoplasms</subject><subj-group><subject>Gastrointestinal Tumors</subject><subj-group><subject>Gastric Cancer</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancers and Neoplasms</subject><subj-group><subject>Colorectal Cancer</subject></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Toll-like receptors 1&#x2013;9 in small bowel neuroendocrine tumors&#x2013;Clinical significance and prognosis</article-title><alt-title alt-title-type="running-head">Toll-like receptors 1&#x2013;9 in small bowel neuroendocrine tumors</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6716-3029</contrib-id><name><surname>Hiltunen</surname><given-names>Niko</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role><role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor001" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Kemi</surname><given-names>Niko</given-names></name><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8683-2996</contrib-id><name><surname>V&#xE4;yrynen</surname><given-names>Juha P.</given-names></name><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>B&#xF6;hm</surname><given-names>Jan</given-names></name><role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Kauppila</surname><given-names>Joonas H.</given-names></name><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role><xref rid="aff003" ref-type="aff">
<sup>3</sup>
</xref><xref rid="aff004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Huhta</surname><given-names>Heikki</given-names></name><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role><xref rid="aff003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Helminen</surname><given-names>Olli</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff003" ref-type="aff">
<sup>3</sup>
</xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Translational Medicine Research Unit, Medical Research Center, University of Oulu and Oulu University Hospital, Oulu, Finland</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Department of Pathology, Central Finland Central Hospital, Jyv&#xE4;skyl&#xE4;, Finland</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Surgery Research Unit, Medical Research Center, University of Oulu and Oulu University Hospital, Oulu, Finland</addr-line></aff><aff id="aff004"><label>4</label>
<addr-line>Department of Molecular Medicine and Surgery, Karolinska Institutet and Karolinska University Hospital, Upper Gastrointestinal Surgery, Stockholm, Sweden</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Zhang</surname><given-names>Luwen</given-names></name><role>Editor</role><xref rid="edit1" ref-type="aff"/></contrib></contrib-group><aff id="edit1">
<addr-line>University of Nebraska-Lincoln, UNITED STATES</addr-line>
</aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>niko.hiltunen@oulu.fi</email></corresp></author-notes><pub-date pub-type="epub"><day>6</day><month>5</month><year>2024</year></pub-date><pub-date pub-type="collection"><year>2024</year></pub-date><volume>19</volume><issue>5</issue><elocation-id>e0302813</elocation-id><history><date date-type="received"><day>8</day><month>11</month><year>2023</year></date><date date-type="accepted"><day>12</day><month>4</month><year>2024</year></date></history><permissions><copyright-statement>&#xA9; 2024 Hiltunen et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Hiltunen et al</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0302813.pdf"/><abstract><p>Toll-like receptors (TLRs) are pattern recognition receptors of the innate immunity. TLRs are known to mediate both antitumor effects and tumorigenesis. TLRs are abundant in many cancers, but their expression in small bowel neuroendocrine tumors (SB-NETs) is unknown. We aimed to characterize the expression of TLRs 1&#x2013;9 in SB-NETs and lymph node metastases and evaluate their prognostic relevance. The present study included 125 patients with SB-NETs, of whom 95 had lymph node metastases, from two Finnish hospitals. Tissue samples were stained immunohistochemically for TLR expression, assessed based on cytoplasmic and nucleic staining intensity and percentage of positively stained cells. Statistical methods for survival analysis included Kaplan-Meier method and Cox regression adjusted for confounding factors. Disease-specific survival (DSS) was the primary outcome. TLRs 1&#x2013;2 and 4&#x2013;9 were expressed in SB-NETs and lymph node metastases. TLR3 showed no positive staining. In primary SB-NETs, TLRs 1&#x2013;9 were not associated with survival. For lymph node metastases, high cytoplasmic TLR7 intensity associated with worse DSS compared to low cytoplasmic intensity (26.4% vs. 84.9%, p = 0.028). Adjusted mortality hazard (HR) was 3.90 (95% CI 1.07&#x2013;14.3). The expression of TLRs 1&#x2013;6 and 8&#x2013;9 in lymph node metastases were not associated with survival. SB-NETs and their lymph node metastases express cytoplasmic TLR 1&#x2013;2 and 4&#x2013;9 and nucleic TLR5. High TLR7 expression in SB-NET lymph node metastases was associated with worse prognosis. The current research has future perspective, as it can help create base for clinical drug trials to target specific TLRs with agonists or antagonists to treat neuroendocrine tumors.</p></abstract><funding-group><award-group id="award001"><funding-source>
<institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100008723</institution-id><institution>Suomen L&#xE4;&#xE4;ketieteen S&#xE4;&#xE4;ti&#xF6;</institution></institution-wrap>
</funding-source><award-id>5954</award-id><principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6716-3029</contrib-id>
<name><surname>Hiltunen</surname><given-names>Niko</given-names></name>
</principal-award-recipient></award-group><award-group id="award002"><funding-source>
<institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100015738</institution-id><institution>Mary och Georg C. Ehrnrooths Stiftelse</institution></institution-wrap>
</funding-source><principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6716-3029</contrib-id>
<name><surname>Hiltunen</surname><given-names>Niko</given-names></name>
</principal-award-recipient></award-group><award-group id="award003"><funding-source>
<institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100015738</institution-id><institution>Mary och Georg C. Ehrnrooths Stiftelse</institution></institution-wrap>
</funding-source><principal-award-recipient>
<name><surname>Helminen</surname><given-names>Olli</given-names></name>
</principal-award-recipient></award-group><award-group id="award004"><funding-source>
<institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100008413</institution-id><institution>Instrumentariumin Tiedes&#xE4;&#xE4;ti&#xF6;</institution></institution-wrap>
</funding-source><principal-award-recipient>
<name><surname>Helminen</surname><given-names>Olli</given-names></name>
</principal-award-recipient></award-group><award-group id="award005"><funding-source>
<institution>Finnish State Research Funding / Valtion tutkimusrahoitus (VTR)</institution>
</funding-source><principal-award-recipient>
<name><surname>Helminen</surname><given-names>Olli</given-names></name>
</principal-award-recipient></award-group><funding-statement>This study was funded by The Finnish Medical Foundation grant no. 5954 (NH), Mary and Georg C. Ehrnrooth Foundation (NH, OH), Instrumentarium Science Foundation (OH) and Finnish State Research Funding (OH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="2"/><table-count count="12"/><page-count count="21"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data (anonymized) are within the manuscript and its <xref rid="sec014" ref-type="sec">Supporting Information</xref> files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data (anonymized) are within the manuscript and its <xref rid="sec014" ref-type="sec">Supporting Information</xref> files.</p></notes></front>
  <body>
    <sec sec-type="intro" id="sec001">
      <title>Introduction</title>
      <p>Neuroendocrine tumors (NETs) can originate in almost any location in the body that contains neuroendocrine cells [<xref rid="pone.0302813.ref001" ref-type="bibr">1</xref>]. The incidence of NETs has increased steadily over the past decades which suggests that the incidence may not have yet reached its peak [<xref rid="pone.0302813.ref002" ref-type="bibr">2</xref>,<xref rid="pone.0302813.ref003" ref-type="bibr">3</xref>]. The incidence of NETs has increased 6.4-fold between 1973 and 2012, according to the SEER database [<xref rid="pone.0302813.ref003" ref-type="bibr">3</xref>]. Small bowel neuroendocrine tumors (SB-NETs) comprise approximately 13&#x2013;28% of the gastroenteropancreatic NETs. Jejunum and ileum are the most common sites for SB-NETs [<xref rid="pone.0302813.ref004" ref-type="bibr">4</xref>,<xref rid="pone.0302813.ref005" ref-type="bibr">5</xref>]. NETs differ in behavior and especially patient survival depending on multiple factors such as tumor location, histology, stage, age, and sex. The 5-year overall survival for grade 1 and 2 SB-NETs is 54&#x2013;71% depending on disease stage whereas 10-year survival is 30&#x2013;49%. The median survival time is 115 months for jejunal/ileal disease [<xref rid="pone.0302813.ref006" ref-type="bibr">6</xref>].</p>
      <p>Toll-like receptors (TLRs) are important mediators of the innate immune system. TLRs are pattern recognition receptors (PRR) that distinguish between self and non-self by identifying pathogen associated molecular patterns (PAMPs) and danger associated molecular patterns (DAMPs). PAMPS are exogenous ligands of microbial components whereas DAMPs are endogenous ligands released into the circulation in cellular stress or necrosis [<xref rid="pone.0302813.ref007" ref-type="bibr">7</xref>,<xref rid="pone.0302813.ref008" ref-type="bibr">8</xref>]. TLRs are type 1 transmembrane proteins consisting of unique cytoplasmic and extracellular antigen-recognition domains [<xref rid="pone.0302813.ref008" ref-type="bibr">8</xref>]. The recognition of PAMPs and DAMPs by TLRs launches a signaling cascade that ultimately leads to the activation of several transcription factors and the production of cytokines and chemokines as an immunologic response [<xref rid="pone.0302813.ref009" ref-type="bibr">9</xref>]. TLR1 recognizes bacterial lipoproteins in an interaction with TLR2 [<xref rid="pone.0302813.ref010" ref-type="bibr">10</xref>]. TLR2 recognizes a variety of microbial components including lipoproteins, peptidoglycan and lipoteichoic acid [<xref rid="pone.0302813.ref009" ref-type="bibr">9</xref>,<xref rid="pone.0302813.ref011" ref-type="bibr">11</xref>]. TLR3 recognizes double stranded viral RNA [<xref rid="pone.0302813.ref012" ref-type="bibr">12</xref>]. TLR4 recognizes lipopolysaccharides and several other ligands such as taxol and endogenous ligands like heat shock proteins [<xref rid="pone.0302813.ref007" ref-type="bibr">7</xref>,<xref rid="pone.0302813.ref013" ref-type="bibr">13</xref>]. TLR5 responds to flagellin, a structural protein component of the flagella of Gram-negative bacteria [<xref rid="pone.0302813.ref014" ref-type="bibr">14</xref>]. TLR6 recognizes di-acyl lipopeptides and has also been shown to functionally cooperate with TLR2 to differentiate between di- and tri-acyl lipopeptides [<xref rid="pone.0302813.ref007" ref-type="bibr">7</xref>,<xref rid="pone.0302813.ref015" ref-type="bibr">15</xref>]. TLRs 7 and 8 both recognize single stranded RNA [<xref rid="pone.0302813.ref009" ref-type="bibr">9</xref>,<xref rid="pone.0302813.ref016" ref-type="bibr">16</xref>]. TLR9 is responsible for directly recognizing bacterial DNA with unmethylated cytosine-phosphate-guanine motifs [<xref rid="pone.0302813.ref017" ref-type="bibr">17</xref>]. In humans, TLR10 is the latest discovered TLR and its ligands and functions remain unclear [<xref rid="pone.0302813.ref018" ref-type="bibr">18</xref>,<xref rid="pone.0302813.ref019" ref-type="bibr">19</xref>]. TLRs 1, 2, 4, 5, and 6 detect extracellular ligands and TLRs 3, 7, 8, and 9 detect intracellular ligands [<xref rid="pone.0302813.ref009" ref-type="bibr">9</xref>].</p>
      <p>There has been growing interest around the expression of TLRs in cancer over the last years. Chronic inflammation plays a notable role in the pathogenesis of various gastrointestinal tract cancers such as gastric cancer and hepatocellular carcinoma [<xref rid="pone.0302813.ref020" ref-type="bibr">20</xref>,<xref rid="pone.0302813.ref021" ref-type="bibr">21</xref>]. TLR activation has been shown to upregulate the production of proangiogenic factors, promote invasiveness and cancer cell adhesion, and amplify tumor metastasis [<xref rid="pone.0302813.ref022" ref-type="bibr">22</xref>]. Some studies on the other hand have shown TLR activation to have antitumoral effect by improving the antitumoral immune response, acting on immune cells or directly on tumor cells [<xref rid="pone.0302813.ref023" ref-type="bibr">23</xref>]. The expression of TLRs in SB-NETs is completely unknown.</p>
      <p>The aim of the present study was to characterize the expression of TLRs 1&#x2013;9 in SB-NETs and lymph node metastases and investigate the correlation of expression with survival and clinicopathological variables in a large retrospective consecutive series of SB-NETs from two Finnish institutions with long follow-up and complete survival data. In this study, expression of TLRs 1&#x2013;9 in SB-NETs was characterized for the first time.</p>
    </sec>
    <sec sec-type="materials|methods" id="sec002">
      <title>Materials and methods</title>
      <sec id="sec003">
        <title>Patients and data collection</title>
        <p>The initial cohort and data collection have been previously described [<xref rid="pone.0302813.ref024" ref-type="bibr">24</xref>]. The original data was collected between February 1, 2019 and May 1, 2019. The data was updated regarding follow-up information and survival data on April 19, 2021. The statistical analyses were performed between July 27, 2023 and August 5, 2023. This study included 125 patients who had been diagnosed and treated in Oulu University Hospital (n = 98) from February 9, 2000 until February 7, 2018 and Central Finland Central Hospital (n = 27) from February 24, 2000 until December 31, 2017. At the time of diagnosis, 76% (n = 95) of these patients presented with lymph node metastases and samples from these were also included. Clinical data were collected from electronic health record by NH and OH. The compiled dataset was anonymized. Survival data were provided by The Cause of Death Registry maintained by Statistics Finland. The end of follow-up was December 31, 2019. The study and use of samples and data was approved by the Oulu University Ethics Committee (EETTMK 81/2008). The National Authority for Medicolegal Affairs (VALVIRA) waived the need for written informed consent due to the retrospective nature of the study and approved for the use of data and samples.</p>
        <p>Experienced pathologists determined the histological diagnoses at the time of treatment. Tumor stage was determined according to the 8<sup>th</sup> edition of the AJCC/UICC Tumor, Node, Metastasis (TNM) categories [<xref rid="pone.0302813.ref025" ref-type="bibr">25</xref>]. Tumor grade was determined according to the WHO 2019 classification of tumors of the digestive system [<xref rid="pone.0302813.ref026" ref-type="bibr">26</xref>].</p>
      </sec>
      <sec id="sec004">
        <title>Immunohistochemical staining</title>
        <p>Routine diagnostic tissue samples from both SB-NETs and lymph node metastases were fixed in formalin and embedded in paraffin. Representative samples including deepest tumor invasion were identified based on diagnostic hematoxylin-eosin slides. For immunohistochemistry, the tissue sample blocks were fetched from archives of the Department of Pathology of Oulu University Hospital and Central Finland Central Hospital and cut in tissue sections of 3.5 &#x3BC;m in thickness. The sections were deparaffinized in xylene and rehydrated through graded alcohols.</p>
        <p>Antigen retrieval was performed with tris-EDTA buffer at pH 9 in a microwave oven first at 800W for 2 minutes and then at 150W for 15 minutes. Tissue sections were first cooled at room temperature for 20 minutes, then rinsed in distilled water and in phosphate-buffered saline containing Tween (PBS-Tween). Endogenous peroxidase activity was neutralized in peroxidase blocking solution (Dako, Glostrup, Denmark, S2023) for 5 minutes, and the tissue sections were washed in PBS-Tween for two 5-minute cycles. After this, sections were incubated with rabbit polyclonal antibodies (TLRs 1, 2, 6, 7) and mouse monoclonal antibodies (TLRs 3, 4, 5, 8, 9) in dilute solution (Dako S2022); TLR1 for 60 minutes (diluted 1:300, Abcam ab189337), TLR2 for 60 minutes (diluted 1:500, Rockland 600-401-956), TLR3 for 120 minutes (diluted 1:30, Novus NBP2-24875), TLR4 for 60 minutes (diluted 1:1000, Abnova H00007099-M02), TLR5 for overnight in +4&#xB0;C (diluted 1:75, Novus NBP2-24787), TLR6 for 60 minutes (diluted 1:750, Abnova PAB 3555), TLR7 for 60 minutes (diluted 1:500, Novus NB100-56682), TLR8 for 60 minutes (diluted 1:850, Novus NBP2-24917) and TLR9 for 60 minutes (diluted 1:300, Novus NBP2-24729). After incubation, wash in PBS-Tween was repeated twice for 5 minutes. The sections were then incubated with En-Vision polymer (Dako K5007) for 30 minutes and again washed in PBS-Tween for two cycles of 5 minutes. After the final wash, diaminobenzidine working solution (Dako K5007) was used as a chromogen. Lastly, the samples were rinsed in distilled water and counterstained in hematoxylin for 1 minute. Staining was done with Dako Autostainer (Dako, Copenhagen, Denmark). Cancer tissues with high expression of TLR were used as external positive controls. To confirm the antigen preservation in the old paraffin blocks we compared the staining intensities in SB-NETs between old and new blocks divided by the median age of the blocks. No significant differences were found.</p>
      </sec>
      <sec id="sec005">
        <title>Immunostaining assessment</title>
        <p>Microscopic slides were scanned at x20 magnification using an Aperio AT2 digital slide scanner. Immunoreactivity of TLRs 1&#x2013;9 was independently evaluated by two researchers (NH and NK) using QuPath [<xref rid="pone.0302813.ref027" ref-type="bibr">27</xref>]. We assessed cytoplasmic and nucleic staining intensity on a scale from zero to three (0&#x2013;3), zero meaning no staining, one meaning weak staining, two meaning intermediate staining and three meaning strongest intensity of staining. We also assessed the percentage of positively stained cells (0&#x2013;100%). All samples with intensity &#x2265; 1 presented with 100% positive tumor cells so only the intensity variable was used for statistical analyses. Mean values of two independent evaluations were used. Dichotomization into groups of low and high intensity was done for all TLR intensity variables. Medians were chosen as cut-off values.</p>
      </sec>
      <sec id="sec006">
        <title>Statistical analysis</title>
        <p>The statistical analyses were computed with IBM SPSS statistics 28 for Windows (IBM Corporation, Armonk, NY, USA). The baseline values were compared with chi square test for categorized and with Mann-Whitney U test for continuous variables. Survival time was from the date of surgery until either time of death or end of follow-up, whichever came first. The Kaplan-Meier method with log-rank test stratified by TLR intensity (low or high) was used to calculate disease specific survival (DSS). Cox regression was used to calculate crude and adjusted hazard ratios (HR). Cox regression was adjusted for age, sex, stage (I-II, III, IV), grade (G1, G2) and adjuvant somatostatin therapy (no, yes). P-values of less than 0.05 were considered significant.</p>
      </sec>
    </sec>
    <sec sec-type="results" id="sec007">
      <title>Results</title>
      <sec id="sec008">
        <title>Patients</title>
        <p>The number of adequate samples and representative immunostainings varied between different TLR stainings. Of the total cohort of 125 SB-NETs, analyzable samples were available for 116 (TLR1), 84 (TLR2), 116 (TLR4), 99 (TLR5), 115 (TLR6), 111 (TLR7), 113 (TLR8) and 111 (TLR9) cases. Of the 95 lymph node metastases, analyzable samples were available for 70 (TLR1), 72 (TLR2), 77 (TLR4), 58 (TLR5), 76 (TLR6), 72 (TLR7), 76 (TLR8) and 70 (TLR9) cases.</p>
        <p>In the total cohort of 125 patients, 57 (45.6%) were women and 68 (54.4%) were men, the median age being 66 years (IQR 55&#x2013;73). Median follow-up time was 70 months (IQR 40&#x2013;125, Range 229). Of the tumors, 16 (12.9%) were stage I-II, 63 (50.8%) were stage III and 45 (36.3%) were stage IV. Forty-four deaths occurred during follow-up and 26 of these deaths were disease-specific. Overall survival during the whole follow up was 41.0%. Baseline characteristics are presented separately and divided between low and high intensity groups for TLR1 (<xref rid="pone.0302813.t001" ref-type="table">Table 1</xref>), TLR2 (<xref rid="pone.0302813.t002" ref-type="table">Table 2</xref>), TLR4 (<xref rid="pone.0302813.t003" ref-type="table">Table 3</xref>), TLR5 (Tables <xref rid="pone.0302813.t004" ref-type="table">4</xref> and <xref rid="pone.0302813.t005" ref-type="table">5</xref>), TLR6 (<xref rid="pone.0302813.t006" ref-type="table">Table 6</xref>), TLR7 (<xref rid="pone.0302813.t007" ref-type="table">Table 7</xref>), TLR8 (<xref rid="pone.0302813.t008" ref-type="table">Table 8</xref>), and TLR9 (<xref rid="pone.0302813.t009" ref-type="table">Table 9</xref>).</p>
        <table-wrap position="float" id="pone.0302813.t001">
          <object-id pub-id-type="doi">10.1371/journal.pone.0302813.t001</object-id>
          <label>Table 1</label>
          <caption>
            <title>Baseline characteristics and comparison stratified by Toll-like receptor (TLR) 1 cytoplasmic intensity in primary tumors and lymph node metastases.</title>
          </caption>
          <alternatives>
            <graphic xlink:href="pone.0302813.t001" id="pone.0302813.t001g" position="float"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="center" rowspan="1" colspan="1">Variables</th>
                  <th align="left" rowspan="1" colspan="1">TLR1 primary tumor cytoplasmic intensity<break/>low, <italic toggle="yes">n</italic> = <italic toggle="yes">71</italic></th>
                  <th align="center" rowspan="1" colspan="1">TLR1 primary tumor cytoplasmic intensity<break/>high, <italic toggle="yes">n</italic> = <italic toggle="yes">45</italic></th>
                  <th align="center" rowspan="1" colspan="1">P between groups</th>
                  <th align="center" rowspan="1" colspan="1">TLR1 metastasis cytoplasmic intensity<break/>low, <italic toggle="yes">n</italic> = 61</th>
                  <th align="center" rowspan="1" colspan="1">TLR1 metastasis cytoplasmic intensity<break/>high, <italic toggle="yes">n</italic> = 9</th>
                  <th align="center" rowspan="1" colspan="1">P between groups</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Sex</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.217</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.588</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Male, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">43 (60.6)</td>
                  <td align="center" rowspan="1" colspan="1">22 (48.9)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">33 (54.1)</td>
                  <td align="center" rowspan="1" colspan="1">4 (44.4)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Female, n (%)</td>
                  <td align="center" rowspan="1" colspan="1">28 (39.4)</td>
                  <td align="center" rowspan="1" colspan="1">23 (51.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">28 (45.9)</td>
                  <td align="center" rowspan="1" colspan="1">5 (55.6)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1"><bold>Age, median (IQR)</bold> years</td>
                  <td align="center" rowspan="1" colspan="1">62.026 (54.084&#x2013;72.17)</td>
                  <td align="center" rowspan="1" colspan="1">67.55 (57.34&#x2013;74.78)</td>
                  <td align="center" rowspan="1" colspan="1">0.169</td>
                  <td align="center" rowspan="1" colspan="1">65.64 (55.66&#x2013;71.30)</td>
                  <td align="center" rowspan="1" colspan="1">69.43 (60.21&#x2013;73.33)</td>
                  <td align="center" rowspan="1" colspan="1">0.376</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>T-Class</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.399</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.962</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">T1&#x2013;2, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">22 (31.0)</td>
                  <td align="center" rowspan="1" colspan="1">9 (20.0)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">13 (21.3)</td>
                  <td align="center" rowspan="1" colspan="1">2 (22.2)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">T3, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">28 (39.4)</td>
                  <td align="center" rowspan="1" colspan="1">22 (48.9)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">30 (49.2)</td>
                  <td align="center" rowspan="1" colspan="1">4 (44.4)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">T4, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">21 (29.6)</td>
                  <td align="center" rowspan="1" colspan="1">14 (31.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">18 (29.5)</td>
                  <td align="center" rowspan="1" colspan="1">3 (33.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>N-Class</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.538</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">N0, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">16 (22.5)</td>
                  <td align="center" rowspan="1" colspan="1">8 (17.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">N1&#x2013;2, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">55 (77.5)</td>
                  <td align="center" rowspan="1" colspan="1">37 (82.2)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>M-Class</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.089</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.064</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">M0, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">41 (57.7)</td>
                  <td align="center" rowspan="1" colspan="1">33 (73.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">40 (65.6)</td>
                  <td align="center" rowspan="1" colspan="1">3 (33.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">M1, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">30 (42.3)</td>
                  <td align="center" rowspan="1" colspan="1">12 (26.7)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">21 (34.4)</td>
                  <td align="center" rowspan="1" colspan="1">6 (66.7)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Stage</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.176</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.064</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">I&#x2013;II, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">9 (12.7)</td>
                  <td align="center" rowspan="1" colspan="1">5 (11.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0</td>
                  <td align="center" rowspan="1" colspan="1">0</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">III, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">32 (45.1)</td>
                  <td align="center" rowspan="1" colspan="1">28 (62.2)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">40 (65.6)</td>
                  <td align="center" rowspan="1" colspan="1">3 (33.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">IV, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">30 (42.3)</td>
                  <td align="center" rowspan="1" colspan="1">12 (26.7)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">21 (34.4)</td>
                  <td align="center" rowspan="1" colspan="1">6 (66.7)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Grade</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.551</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.771</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">1, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">53 (80.3)</td>
                  <td align="center" rowspan="1" colspan="1">34 (75.6)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">42 (70.0)</td>
                  <td align="center" rowspan="1" colspan="1">6 (75.0)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">2, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">13 (19.7)</td>
                  <td align="center" rowspan="1" colspan="1">11 (24.4)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">18 (30.0)</td>
                  <td align="center" rowspan="1" colspan="1">2 (25.0)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Tumor location</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.567</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.496</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Jejunum, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">5 (7.0)</td>
                  <td align="center" rowspan="1" colspan="1">2 (4.4)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">3 (4.9)</td>
                  <td align="center" rowspan="1" colspan="1">0</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Ileum, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">66 (93.0)</td>
                  <td align="center" rowspan="1" colspan="1">43 (95.6)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">58 (95.1)</td>
                  <td align="center" rowspan="1" colspan="1">9 (100)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Somatostatin analogue treatment</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.395</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.597</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Yes, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">42 (59.2)</td>
                  <td align="center" rowspan="1" colspan="1">23 (51.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">35 (57.4)</td>
                  <td align="center" rowspan="1" colspan="1">6 (66.7)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Chemotherapy</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.594</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.197</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">No, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">60 (84.5)</td>
                  <td align="center" rowspan="1" colspan="1">38 (84.4)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">52 (85.2)</td>
                  <td align="center" rowspan="1" colspan="1">6 (66.7)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Preoperative, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">4 (5.6)</td>
                  <td align="center" rowspan="1" colspan="1">1 (2.2)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">1 (1.6)</td>
                  <td align="center" rowspan="1" colspan="1">1 (11.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Postoperative, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">7 (9.9)</td>
                  <td align="center" rowspan="1" colspan="1">6 (13.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">2 (22.2)</td>
                  <td align="center" rowspan="1" colspan="1">2 (22.2)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Multiple primary tumors</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.404</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.702</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Yes, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">18 (26.1)</td>
                  <td align="center" rowspan="1" colspan="1">15 (33.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">17 (28.3)</td>
                  <td align="center" rowspan="1" colspan="1">2 (22.2)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>P-CgA</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Median (IQR) nmol/L</td>
                  <td align="center" rowspan="1" colspan="1">7.15 (4.00&#x2013;17.00)</td>
                  <td align="center" rowspan="1" colspan="1">5.6 (3.05&#x2013;11.90)</td>
                  <td align="center" rowspan="1" colspan="1">0.083</td>
                  <td align="center" rowspan="1" colspan="1">5.35 (3.30&#x2013;12.00)</td>
                  <td align="center" rowspan="1" colspan="1">5.60 (4.80&#x2013;19.00)</td>
                  <td align="center" rowspan="1" colspan="1">0.422</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>dU-5-HIAA</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Median (IQR) &#x3BC;mol/L</td>
                  <td align="center" rowspan="1" colspan="1">54.5 (25.75&#x2013;176.25)</td>
                  <td align="center" rowspan="1" colspan="1">84.50 (27.25&#x2013;218.50)</td>
                  <td align="center" rowspan="1" colspan="1">0.620</td>
                  <td align="center" rowspan="1" colspan="1">77.00 (38.00&#x2013;169.00)</td>
                  <td align="center" rowspan="1" colspan="1">56.00 (38.75&#x2013;168.25)</td>
                  <td align="center" rowspan="1" colspan="1">0.902</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="t001fn001">
              <p>P-CgA, plasma chromogranin A; dU-5-HIAA, 24 h urine 5-hydroxyindoleacetic acid; Classes T-, N- and M refer to Tumor, Node and Metastasis of the TNM-staging system.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <table-wrap position="float" id="pone.0302813.t002">
          <object-id pub-id-type="doi">10.1371/journal.pone.0302813.t002</object-id>
          <label>Table 2</label>
          <caption>
            <title>Baseline characteristics and comparison stratified by Toll-like receptor (TLR) 2 cytoplasmic intensity in primary tumors and lymph node metastases.</title>
          </caption>
          <alternatives>
            <graphic xlink:href="pone.0302813.t002" id="pone.0302813.t002g" position="float"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="center" rowspan="1" colspan="1">Variables</th>
                  <th align="left" rowspan="1" colspan="1">TLR2 primary tumor cytoplasmic intensity<break/>low, <italic toggle="yes">n</italic> = <italic toggle="yes">52</italic></th>
                  <th align="center" rowspan="1" colspan="1">TLR2 primary tumor cytoplasmic intensity<break/>high, <italic toggle="yes">n</italic> = <italic toggle="yes">32</italic></th>
                  <th align="center" rowspan="1" colspan="1">P between groups</th>
                  <th align="center" rowspan="1" colspan="1">TLR2 metastasis cytoplasmic intensity<break/>low, <italic toggle="yes">n</italic> = <italic toggle="yes">37</italic></th>
                  <th align="center" rowspan="1" colspan="1">TLR2 metastasis cytoplasmic intensity<break/>high, <italic toggle="yes">n</italic> = 35</th>
                  <th align="center" rowspan="1" colspan="1">P between groups</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Sex</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.091</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.824</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Male, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">31 (59.6)</td>
                  <td align="center" rowspan="1" colspan="1">13 (40.6)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">20 (54.1)</td>
                  <td align="center" rowspan="1" colspan="1">18 (51.4)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Female, n (%)</td>
                  <td align="center" rowspan="1" colspan="1">21 (40.4)</td>
                  <td align="center" rowspan="1" colspan="1">19 (59.4)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">17 (45.9)</td>
                  <td align="center" rowspan="1" colspan="1">17 (48.6)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1"><bold>Age, median (IQR)</bold> years</td>
                  <td align="center" rowspan="1" colspan="1">65.55 (54.13&#x2013;72.50)</td>
                  <td align="center" rowspan="1" colspan="1">65.80 (57.28&#x2013;73.25)</td>
                  <td align="center" rowspan="1" colspan="1">0.665</td>
                  <td align="center" rowspan="1" colspan="1">64.83 (54.70&#x2013;72.70)</td>
                  <td align="center" rowspan="1" colspan="1">67.55 (56.27&#x2013;73.71)</td>
                  <td align="center" rowspan="1" colspan="1">0.414</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>T-Class</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.413</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.552</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">T1&#x2013;2, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">14 (26.9)</td>
                  <td align="center" rowspan="1" colspan="1">10 (31.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">7 (18.9)</td>
                  <td align="center" rowspan="1" colspan="1">10 (28.6)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">T3, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">22 (42.3)</td>
                  <td align="center" rowspan="1" colspan="1">9 (28.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">20 (54.1)</td>
                  <td align="center" rowspan="1" colspan="1">15 (42.9)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">T4, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">16 (30.8)</td>
                  <td align="center" rowspan="1" colspan="1">13 (40.6)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">10 (27.0)</td>
                  <td align="center" rowspan="1" colspan="1">10 (28.6)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>N-Class</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.770</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">N0, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">10 (19.2)</td>
                  <td align="center" rowspan="1" colspan="1">7 (21.9)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">N1&#x2013;2, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">42 (80.8)</td>
                  <td align="center" rowspan="1" colspan="1">25 (78.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>M-Class</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.511</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.951</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">M0, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">33 (63.5)</td>
                  <td align="center" rowspan="1" colspan="1">18 (56.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">23 (62.2)</td>
                  <td align="center" rowspan="1" colspan="1">22 (62.9)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">M1, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">19 (36.5)</td>
                  <td align="center" rowspan="1" colspan="1">14 (43.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">14 (37.8)</td>
                  <td align="center" rowspan="1" colspan="1">13 (37.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Stage</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.799</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.951</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">I&#x2013;II, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">6 (11.5)</td>
                  <td align="center" rowspan="1" colspan="1">3 (9.4)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0</td>
                  <td align="center" rowspan="1" colspan="1">0</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">III, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">27 (51.9)</td>
                  <td align="center" rowspan="1" colspan="1">15 (46.9)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">23 (62.2)</td>
                  <td align="center" rowspan="1" colspan="1">22 (62.9)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">IV, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">19 (36.5)</td>
                  <td align="center" rowspan="1" colspan="1">14 (43.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">14 (37.8)</td>
                  <td align="center" rowspan="1" colspan="1">13 (37.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Grade</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.248</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.151</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">1, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">38 (76.0)</td>
                  <td align="center" rowspan="1" colspan="1">26 (86.7)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">23 (63.9)</td>
                  <td align="center" rowspan="1" colspan="1">27 (79.4)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">2, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">12 (24.0)</td>
                  <td align="center" rowspan="1" colspan="1">4 (13.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">13 (36.1)</td>
                  <td align="center" rowspan="1" colspan="1">7 (20.6)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Tumor location</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.262</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.523</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Jejunum, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">2 (3.8)</td>
                  <td align="center" rowspan="1" colspan="1">0</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">1 (2.7)</td>
                  <td align="center" rowspan="1" colspan="1">2 (5.7)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Ileum, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">50 (96.2)</td>
                  <td align="center" rowspan="1" colspan="1">32 (100)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">36 (97.3)</td>
                  <td align="center" rowspan="1" colspan="1">33 (94.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Somatostatin analogue treatment</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.582</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.951</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Yes, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">31 (59.6)</td>
                  <td align="center" rowspan="1" colspan="1">21 (65.6)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">23 (62.2)</td>
                  <td align="center" rowspan="1" colspan="1">22 (62.9)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Chemotherapy</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.180</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.994</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">No, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">42 (80.8)</td>
                  <td align="center" rowspan="1" colspan="1">30 (93.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">31 (83.8)</td>
                  <td align="center" rowspan="1" colspan="1">29 (82.9)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Preoperative, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">4 (7.7)</td>
                  <td align="center" rowspan="1" colspan="1">0</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">1 (2.7)</td>
                  <td align="center" rowspan="1" colspan="1">1 (2.9)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Postoperative, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">6 (11.5)</td>
                  <td align="center" rowspan="1" colspan="1">2 (6.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">5 (13.5)</td>
                  <td align="center" rowspan="1" colspan="1">5 (14.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Multiple primary tumors</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.319</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.664</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Yes, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">16 (32.0)</td>
                  <td align="center" rowspan="1" colspan="1">7 (21.9)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">12 (33.3)</td>
                  <td align="center" rowspan="1" colspan="1">10 (28.6)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>P-CgA</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Median (IQR) nmol/L</td>
                  <td align="center" rowspan="1" colspan="1">6.30 (3.8250&#x2013;20.25)</td>
                  <td align="center" rowspan="1" colspan="1">6.70 (3.70&#x2013;17.00)</td>
                  <td align="center" rowspan="1" colspan="1">0.905</td>
                  <td align="center" rowspan="1" colspan="1">7.05 (3.75&#x2013;12.00)</td>
                  <td align="center" rowspan="1" colspan="1">4.80 (3.375&#x2013;11.00)</td>
                  <td align="center" rowspan="1" colspan="1">0.594</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>dU-5-HIAA</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Median (IQR) &#x3BC;mol/L</td>
                  <td align="center" rowspan="1" colspan="1">77.00 (30.00&#x2013;214.50)</td>
                  <td align="center" rowspan="1" colspan="1">35.00 (24.00&#x2013;254.50)</td>
                  <td align="center" rowspan="1" colspan="1">0.275</td>
                  <td align="center" rowspan="1" colspan="1">84.00 (28.75&#x2013;155.25)</td>
                  <td align="center" rowspan="1" colspan="1">57.50 (40.00&#x2013;176.25)</td>
                  <td align="center" rowspan="1" colspan="1">0.950</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="t002fn001">
              <p>P-CgA, plasma chromogranin A; dU-5-HIAA, 24 h urine 5-hydroxyindoleacetic acid; Classes T-, N- and M refer to Tumor, Node and Metastasis of the TNM-staging system.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <table-wrap position="float" id="pone.0302813.t003">
          <object-id pub-id-type="doi">10.1371/journal.pone.0302813.t003</object-id>
          <label>Table 3</label>
          <caption>
            <title>Baseline characteristics and comparison stratified by Toll-like receptor (TLR) 4 cytoplasmic intensity in primary tumors and lymph node metastases.</title>
          </caption>
          <alternatives>
            <graphic xlink:href="pone.0302813.t003" id="pone.0302813.t003g" position="float"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="center" rowspan="1" colspan="1">Variables</th>
                  <th align="left" rowspan="1" colspan="1">TLR4 primary tumor cytoplasmic intensity<break/>low, <italic toggle="yes">n</italic> = <italic toggle="yes">67</italic></th>
                  <th align="center" rowspan="1" colspan="1">TLR4 primary tumor cytoplasmic intensity<break/>high, <italic toggle="yes">n</italic> = <italic toggle="yes">49</italic></th>
                  <th align="center" rowspan="1" colspan="1">P between groups</th>
                  <th align="center" rowspan="1" colspan="1">TLR4 metastasis cytoplasmic intensity<break/>low, <italic toggle="yes">n</italic> = <italic toggle="yes">48</italic></th>
                  <th align="center" rowspan="1" colspan="1">TLR4 metastasis cytoplasmic intensity<break/>high, <italic toggle="yes">n</italic> = 29</th>
                  <th align="center" rowspan="1" colspan="1">P between groups</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Sex</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.127</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.616</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Male, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">41 (61.2)</td>
                  <td align="center" rowspan="1" colspan="1">23 (46.9)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">26 (54.2)</td>
                  <td align="center" rowspan="1" colspan="1">14 (48.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Female, n (%)</td>
                  <td align="center" rowspan="1" colspan="1">26 (38.8)</td>
                  <td align="center" rowspan="1" colspan="1">26 (53.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">22 (45.8)</td>
                  <td align="center" rowspan="1" colspan="1">15 (51.7)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1"><bold>Age, median (IQR)</bold> years</td>
                  <td align="center" rowspan="1" colspan="1">58.10 (50.10&#x2013;72.17)</td>
                  <td align="center" rowspan="1" colspan="1">68.01 (63.35&#x2013;73.75)</td>
                  <td align="center" rowspan="1" colspan="1">
<bold>0.002</bold>
</td>
                  <td align="center" rowspan="1" colspan="1">65.92 (55.51&#x2013;71.36)</td>
                  <td align="center" rowspan="1" colspan="1">66.51 (57.36&#x2013;74.44)</td>
                  <td align="center" rowspan="1" colspan="1">0.690</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>T-Class</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.167</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.900</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">T1&#x2013;2, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">21 (31.3)</td>
                  <td align="center" rowspan="1" colspan="1">8 (16.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">10 (20.8)</td>
                  <td align="center" rowspan="1" colspan="1">7 (24.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">T3, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">26 (38.8)</td>
                  <td align="center" rowspan="1" colspan="1">25 (51.0)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">24 (50.0)</td>
                  <td align="center" rowspan="1" colspan="1">13 (44.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">T4, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">20 (29.9)</td>
                  <td align="center" rowspan="1" colspan="1">16 (32.7)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">14 (29.2)</td>
                  <td align="center" rowspan="1" colspan="1">9 (31.0)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>N-Class</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.200</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">N0, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">16 (23.9)</td>
                  <td align="center" rowspan="1" colspan="1">7 (14.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">N1&#x2013;2, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">51 (76.1)</td>
                  <td align="center" rowspan="1" colspan="1">42 (85.7)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>M-Class</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.192</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.213</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">M0, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">40 (59.7)</td>
                  <td align="center" rowspan="1" colspan="1">35 (71.4)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">28 (58.3)</td>
                  <td align="center" rowspan="1" colspan="1">21 (72.4)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">M1, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">27 (40.3)</td>
                  <td align="center" rowspan="1" colspan="1">14 (28.6)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">20 (41.7)</td>
                  <td align="center" rowspan="1" colspan="1">8 (27.6)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Stage</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.134</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.213</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">I&#x2013;II, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">10 (14.9)</td>
                  <td align="center" rowspan="1" colspan="1">4 (8.2)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0</td>
                  <td align="center" rowspan="1" colspan="1">0</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">III, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">30 (44.8)</td>
                  <td align="center" rowspan="1" colspan="1">31 (63.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">28 (58.3)</td>
                  <td align="center" rowspan="1" colspan="1">21 (72.4)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">IV, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">27 (40.3)</td>
                  <td align="center" rowspan="1" colspan="1">14 (28.6)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">20 (41.7)</td>
                  <td align="center" rowspan="1" colspan="1">8 (27.6)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Grade</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.401</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.408</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">1, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">53 (81.5)</td>
                  <td align="center" rowspan="1" colspan="1">36 (75.0)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">36 (76.6)</td>
                  <td align="center" rowspan="1" colspan="1">19 (67.9)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">2, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">12 (18.5)</td>
                  <td align="center" rowspan="1" colspan="1">12 (25.0)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">11 (23.4)</td>
                  <td align="center" rowspan="1" colspan="1">9 (31.2)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Tumor location</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.973</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.875</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Jejunum, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">4 (6.0)</td>
                  <td align="center" rowspan="1" colspan="1">3 (6.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">2 (4.2)</td>
                  <td align="center" rowspan="1" colspan="1">1 (3.4)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Ileum, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">63 (94.0)</td>
                  <td align="center" rowspan="1" colspan="1">46 (93.9)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">46 (95.8)</td>
                  <td align="center" rowspan="1" colspan="1">28 (96.6)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Somatostatin analogue treatment</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.127</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.601</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Yes, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">41 (61.2)</td>
                  <td align="center" rowspan="1" colspan="1">23 (46.9)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">31 (64.6)</td>
                  <td align="center" rowspan="1" colspan="1">17 (58.6)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Chemotherapy</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.131</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.167</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">No, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">55 (82.1)</td>
                  <td align="center" rowspan="1" colspan="1">44 (89.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">41 (85.4)</td>
                  <td align="center" rowspan="1" colspan="1">24 (82.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Preoperative, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">2 (3.0)</td>
                  <td align="center" rowspan="1" colspan="1">3 (6.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0</td>
                  <td align="center" rowspan="1" colspan="1">2 (6.9)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Postoperative, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">10 (14.9)</td>
                  <td align="center" rowspan="1" colspan="1">2 (4.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">7 (14.6)</td>
                  <td align="center" rowspan="1" colspan="1">3 (10.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Multiple primary tumors</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.324</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.403</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Yes, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">17 (26.2)</td>
                  <td align="center" rowspan="1" colspan="1">17 (34.7)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">12 (25.5)</td>
                  <td align="center" rowspan="1" colspan="1">10 (34.5)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>P-CgA</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Median (IQR) nmol/L</td>
                  <td align="center" rowspan="1" colspan="1">5.90 (3.525&#x2013;13.50)</td>
                  <td align="center" rowspan="1" colspan="1">6.90 (3.80&#x2013;15.50)</td>
                  <td align="center" rowspan="1" colspan="1">0.485</td>
                  <td align="center" rowspan="1" colspan="1">6.10 (3.55&#x2013;11.45)</td>
                  <td align="center" rowspan="1" colspan="1">6.30 (3.45&#x2013;14.25)</td>
                  <td align="center" rowspan="1" colspan="1">0.827</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>dU-5-HIAA</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Median (IQR) &#x3BC;mol/L</td>
                  <td align="center" rowspan="1" colspan="1">58.00 (27.00&#x2013;156.00)</td>
                  <td align="center" rowspan="1" colspan="1">48.50 (22.75&#x2013;196.00)</td>
                  <td align="center" rowspan="1" colspan="1">0.697</td>
                  <td align="center" rowspan="1" colspan="1">63 (35.75&#x2013;131.25)</td>
                  <td align="center" rowspan="1" colspan="1">105.50 (31.00&#x2013;258.75)</td>
                  <td align="center" rowspan="1" colspan="1">0.339</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="t003fn001">
              <p>P-CgA, plasma chromogranin A; dU-5-HIAA, 24 h urine 5-hydroxyindoleacetic acid; Classes T-, N- and M refer to Tumor, Node and Metastasis of the TNM-staging system.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <table-wrap position="float" id="pone.0302813.t004">
          <object-id pub-id-type="doi">10.1371/journal.pone.0302813.t004</object-id>
          <label>Table 4</label>
          <caption>
            <title>Baseline characteristics and comparison stratified by Toll-like receptor (TLR) 5 cytoplasmic intensity in primary tumors and lymph node metastases.</title>
          </caption>
          <alternatives>
            <graphic xlink:href="pone.0302813.t004" id="pone.0302813.t004g" position="float"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="center" rowspan="1" colspan="1">Variables</th>
                  <th align="left" rowspan="1" colspan="1">TLR5 primary tumor cytoplasmic intensity<break/>low, <italic toggle="yes">n</italic> = <italic toggle="yes">53</italic></th>
                  <th align="center" rowspan="1" colspan="1">TLR5 primary tumor cytoplasmic intensity<break/>high, <italic toggle="yes">n</italic> = <italic toggle="yes">46</italic></th>
                  <th align="center" rowspan="1" colspan="1">P between groups</th>
                  <th align="center" rowspan="1" colspan="1">TLR5 metastasis cytoplasmic intensity<break/>low, <italic toggle="yes">n</italic> = <italic toggle="yes">49</italic></th>
                  <th align="center" rowspan="1" colspan="1">TLR5 metastasis cytoplasmic intensity<break/>high, <italic toggle="yes">n</italic> = 9</th>
                  <th align="center" rowspan="1" colspan="1">P between groups</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Sex</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.411</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.451</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Male, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">32 (60.4)</td>
                  <td align="center" rowspan="1" colspan="1">24 (52.2)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">26 (53.1)</td>
                  <td align="center" rowspan="1" colspan="1">6 (66.7)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Female, n (%)</td>
                  <td align="center" rowspan="1" colspan="1">21 (39.6)</td>
                  <td align="center" rowspan="1" colspan="1">22 (47.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">23 (46.9)</td>
                  <td align="center" rowspan="1" colspan="1">3 (33.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1"><bold>Age, median (IQR)</bold> years</td>
                  <td align="center" rowspan="1" colspan="1">61.34 (51.75&#x2013;71.30)</td>
                  <td align="center" rowspan="1" colspan="1">65.84 (55.67&#x2013;73.05)</td>
                  <td align="center" rowspan="1" colspan="1">0.351</td>
                  <td align="center" rowspan="1" colspan="1">64.83 (56.00&#x2013;72.56)</td>
                  <td align="center" rowspan="1" colspan="1">67.99 (55.10&#x2013;74.36)</td>
                  <td align="center" rowspan="1" colspan="1">0.660</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>T-Class</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.974</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.703</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">T1&#x2013;2, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">14 (26.4)</td>
                  <td align="center" rowspan="1" colspan="1">13 (28.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">11 (22.4)</td>
                  <td align="center" rowspan="1" colspan="1">3 (33.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">T3, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">22 (41.5)</td>
                  <td align="center" rowspan="1" colspan="1">19 (41.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">23 (46.9)</td>
                  <td align="center" rowspan="1" colspan="1">3 (33.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">T4, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">17 (32.1)</td>
                  <td align="center" rowspan="1" colspan="1">14 (30.4)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">15 (30.6)</td>
                  <td align="center" rowspan="1" colspan="1">3 (33.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>N-Class</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.148</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">N0, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">13 (24.5)</td>
                  <td align="center" rowspan="1" colspan="1">6 (13.0)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">N1&#x2013;2, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">40 (75.5)</td>
                  <td align="center" rowspan="1" colspan="1">40 (87.0)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>M-Class</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.620</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.576</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">M0, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">32 (60.4)</td>
                  <td align="center" rowspan="1" colspan="1">30 (65.2)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">32 (65.3)</td>
                  <td align="center" rowspan="1" colspan="1">5 (55.6)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">M1, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">21 (39.6)</td>
                  <td align="center" rowspan="1" colspan="1">16 (34.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">17 (34.7)</td>
                  <td align="center" rowspan="1" colspan="1">4 (44.4)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Stage</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.638</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.576</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">I&#x2013;II, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">8 (15.1)</td>
                  <td align="center" rowspan="1" colspan="1">5 (10.9)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0</td>
                  <td align="center" rowspan="1" colspan="1">0</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">III, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">24 (45.3)</td>
                  <td align="center" rowspan="1" colspan="1">25 (54.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">32 (65.3)</td>
                  <td align="center" rowspan="1" colspan="1">5 (55.6)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">IV, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">21 (39.6)</td>
                  <td align="center" rowspan="1" colspan="1">16 (34.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">17 (34.7)</td>
                  <td align="center" rowspan="1" colspan="1">4 (44.4)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Grade</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.484</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.602</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">1, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">41 (78.8)</td>
                  <td align="center" rowspan="1" colspan="1">32 (72.7)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">36 (75.0)</td>
                  <td align="center" rowspan="1" colspan="1">6 (66.7)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">2, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">11 (21.2)</td>
                  <td align="center" rowspan="1" colspan="1">12 (27.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">12 (25.0)</td>
                  <td align="center" rowspan="1" colspan="1">3 (33.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Tumor location</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.533</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.446</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Jejunum, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">2 (3.8)</td>
                  <td align="center" rowspan="1" colspan="1">3 (6.5)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">3 (6.1)</td>
                  <td align="center" rowspan="1" colspan="1">0</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Ileum, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">51 (96.2)</td>
                  <td align="center" rowspan="1" colspan="1">43 (93.5)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">46 (93.9)</td>
                  <td align="center" rowspan="1" colspan="1">9 (100)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Somatostatin analogue treatment</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.425</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.520</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Yes, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">33 (62.3)</td>
                  <td align="center" rowspan="1" colspan="1">25 (54.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">27 (55.1)</td>
                  <td align="center" rowspan="1" colspan="1">6 (66.7)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Chemotherapy</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.874</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.062</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">No, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">45 (84.9)</td>
                  <td align="center" rowspan="1" colspan="1">39 (84.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">44 (89.8)</td>
                  <td align="center" rowspan="1" colspan="1">7 (77.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Preoperative, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">2 (3.8)</td>
                  <td align="center" rowspan="1" colspan="1">1 (2.2)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0</td>
                  <td align="center" rowspan="1" colspan="1">1 (11.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Postoperative, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">6 (11.3)</td>
                  <td align="center" rowspan="1" colspan="1">6 (13.0)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">5 (10.2)</td>
                  <td align="center" rowspan="1" colspan="1">1 (11.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Multiple primary tumors</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.650</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.761</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Yes, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">14 (26.9)</td>
                  <td align="center" rowspan="1" colspan="1">14 (31.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">13 (27.1)</td>
                  <td align="center" rowspan="1" colspan="1">2 (22.2)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>P-CgA</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Median (IQR) nmol/L</td>
                  <td align="center" rowspan="1" colspan="1">6.80 (3.525&#x2013;19.00)</td>
                  <td align="center" rowspan="1" colspan="1">5.50 (3.60&#x2013;9.90)</td>
                  <td align="center" rowspan="1" colspan="1">0.510</td>
                  <td align="center" rowspan="1" colspan="1">5.70 (3.30&#x2013;9.85)</td>
                  <td align="center" rowspan="1" colspan="1">5.95 (4.425&#x2013;13.10)</td>
                  <td align="center" rowspan="1" colspan="1">0.534</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>dU-5-HIAA</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Median (IQR) &#x3BC;mol/L</td>
                  <td align="center" rowspan="1" colspan="1">42.00 (24.00&#x2013;153.00)</td>
                  <td align="center" rowspan="1" colspan="1">92.00 (37.25&#x2013;198.750)</td>
                  <td align="center" rowspan="1" colspan="1">0.258</td>
                  <td align="center" rowspan="1" colspan="1">56.00 (27.00&#x2013;105.00)</td>
                  <td align="center" rowspan="1" colspan="1">67.50 (44.25&#x2013;331.75)</td>
                  <td align="center" rowspan="1" colspan="1">0.266</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="t004fn001">
              <p>P-CgA, plasma chromogranin A; dU-5-HIAA, 24 h urine 5-hydroxyindoleacetic acid; Classes T-, N- and M refer to Tumor, Node and Metastasis of the TNM-staging system.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <table-wrap position="float" id="pone.0302813.t005">
          <object-id pub-id-type="doi">10.1371/journal.pone.0302813.t005</object-id>
          <label>Table 5</label>
          <caption>
            <title>Baseline characteristics and comparison stratified by Toll-like receptor (TLR) 5 nucleic intensity in primary tumors and lymph node metastases.</title>
          </caption>
          <alternatives>
            <graphic xlink:href="pone.0302813.t005" id="pone.0302813.t005g" position="float"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="center" rowspan="1" colspan="1">Variables</th>
                  <th align="left" rowspan="1" colspan="1">TLR5 primary tumor nucleic intensity<break/>low, <italic toggle="yes">n</italic> = <italic toggle="yes">62</italic></th>
                  <th align="center" rowspan="1" colspan="1">TLR5 primary tumor nucleic intensity<break/>high, <italic toggle="yes">n</italic> = <italic toggle="yes">37</italic></th>
                  <th align="center" rowspan="1" colspan="1">P between groups</th>
                  <th align="center" rowspan="1" colspan="1">TLR5 metastasis nucleic intensity<break/>low, <italic toggle="yes">n</italic> = <italic toggle="yes">45</italic></th>
                  <th align="center" rowspan="1" colspan="1">TLR5 metastasis nucleic intensity<break/>high, <italic toggle="yes">n</italic> = 13</th>
                  <th align="center" rowspan="1" colspan="1">P between groups</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Sex</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.976</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.458</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Male, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">35 (56.5)</td>
                  <td align="center" rowspan="1" colspan="1">21 (56.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">26 (57.8)</td>
                  <td align="center" rowspan="1" colspan="1">6 (46.2)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Female, n (%)</td>
                  <td align="center" rowspan="1" colspan="1">27 (43.5)</td>
                  <td align="center" rowspan="1" colspan="1">16 (43.2)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">19 (42.2)</td>
                  <td align="center" rowspan="1" colspan="1">7 (53.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1"><bold>Age, median (IQR)</bold> years</td>
                  <td align="center" rowspan="1" colspan="1">61.68 (51.71&#x2013;72.19)</td>
                  <td align="center" rowspan="1" colspan="1">66.05 (56.19&#x2013;73.38)</td>
                  <td align="center" rowspan="1" colspan="1">0.272</td>
                  <td align="center" rowspan="1" colspan="1">64.33 (55.39&#x2013;71.53)</td>
                  <td align="center" rowspan="1" colspan="1">67.99 (62.33&#x2013;82.63)</td>
                  <td align="center" rowspan="1" colspan="1">0.095</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>T-Class</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.726</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.658</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">T1&#x2013;2, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">17 (27.4)</td>
                  <td align="center" rowspan="1" colspan="1">10 (27.0)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">12 (26.7)</td>
                  <td align="center" rowspan="1" colspan="1">2 (15.4)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">T3, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">24 (38.7)</td>
                  <td align="center" rowspan="1" colspan="1">17 (45.9)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">20 (44.4)</td>
                  <td align="center" rowspan="1" colspan="1">6 (46.2)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">T4, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">21 (33.9)</td>
                  <td align="center" rowspan="1" colspan="1">10 (27.0)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">13 (28.9)</td>
                  <td align="center" rowspan="1" colspan="1">5 (38.5)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>N-Class</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.268</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">N0, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">14 (22.6)</td>
                  <td align="center" rowspan="1" colspan="1">5 (13.5)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">N1&#x2013;2, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">48 (77.4)</td>
                  <td align="center" rowspan="1" colspan="1">32 (86.5)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>M-Class</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.432</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.263</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">M0, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">37 (59.7)</td>
                  <td align="center" rowspan="1" colspan="1">25 (67.6)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">27 (60.0)</td>
                  <td align="center" rowspan="1" colspan="1">10 (76.9)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">M1, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">25 (40.3)</td>
                  <td align="center" rowspan="1" colspan="1">12 (32.4)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">18 (40.0)</td>
                  <td align="center" rowspan="1" colspan="1">3 (23.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Stage</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.533</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.263</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">I&#x2013;II, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">9 (14.5)</td>
                  <td align="center" rowspan="1" colspan="1">4 (10.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0</td>
                  <td align="center" rowspan="1" colspan="1">0</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">III, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">28 (45.2)</td>
                  <td align="center" rowspan="1" colspan="1">21 (56.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">27 (60.0)</td>
                  <td align="center" rowspan="1" colspan="1">10 (76.9)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">IV, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">25 (40.3)</td>
                  <td align="center" rowspan="1" colspan="1">12 (32.4)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">18 (40.0)</td>
                  <td align="center" rowspan="1" colspan="1">3 (23.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Grade</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.422</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.678</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">1, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">48 (78.7)</td>
                  <td align="center" rowspan="1" colspan="1">25 (71.4)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">33 (75.0)</td>
                  <td align="center" rowspan="1" colspan="1">9 (69.2)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">2, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">13 (21.3)</td>
                  <td align="center" rowspan="1" colspan="1">10 (28.6)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">11 (25.0)</td>
                  <td align="center" rowspan="1" colspan="1">4 (30.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Tumor location</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">
<bold>0.043</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.339</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Jejunum, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">1 (1.6)</td>
                  <td align="center" rowspan="1" colspan="1">4 (10.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">3 (6.7)</td>
                  <td align="center" rowspan="1" colspan="1">0</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Ileum, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">61 (98.4)</td>
                  <td align="center" rowspan="1" colspan="1">33 (89.2)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">42 (93.3)</td>
                  <td align="center" rowspan="1" colspan="1">13 (100)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Somatostatin analogue treatment</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.775</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">
<bold>0.005</bold>
</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Yes, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">37 (59.7)</td>
                  <td align="center" rowspan="1" colspan="1">21 (56.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">30 (66.7)</td>
                  <td align="center" rowspan="1" colspan="1">3 (23.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Chemotherapy</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.524</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.073</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">No, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">54 (87.1)</td>
                  <td align="center" rowspan="1" colspan="1">30 (81.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">39 (86.7)</td>
                  <td align="center" rowspan="1" colspan="1">12 (92.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Preoperative, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">1 (1.6)</td>
                  <td align="center" rowspan="1" colspan="1">2 (5.4)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0</td>
                  <td align="center" rowspan="1" colspan="1">1 (7.7)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Postoperative, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">7 (11.3)</td>
                  <td align="center" rowspan="1" colspan="1">5 (13.5)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">6 (13.3)</td>
                  <td align="center" rowspan="1" colspan="1">0</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Multiple primary tumors</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.778</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.308</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Yes, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">17 (27.9)</td>
                  <td align="center" rowspan="1" colspan="1">11 (30.6)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">13 (29.5)</td>
                  <td align="center" rowspan="1" colspan="1">2 (15.4)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>P-CgA</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Median (IQR) nmol/L</td>
                  <td align="center" rowspan="1" colspan="1">6.4 (3.75&#x2013;15.50)</td>
                  <td align="center" rowspan="1" colspan="1">4.90 (3.025&#x2013;9.95)</td>
                  <td align="center" rowspan="1" colspan="1">0.439</td>
                  <td align="center" rowspan="1" colspan="1">4.80 (3.350&#x2013;11.00)</td>
                  <td align="center" rowspan="1" colspan="1">6.70 (3.10&#x2013;8.90)</td>
                  <td align="center" rowspan="1" colspan="1">0.867</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>dU-5-HIAA</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Median (IQR) &#x3BC;mol/L</td>
                  <td align="center" rowspan="1" colspan="1">42.00 (25.00&#x2013;153.0)</td>
                  <td align="center" rowspan="1" colspan="1">107.00 (37.250&#x2013;203.50)</td>
                  <td align="center" rowspan="1" colspan="1">0.230</td>
                  <td align="center" rowspan="1" colspan="1">63.00 (30.250&#x2013;139.00)</td>
                  <td align="center" rowspan="1" colspan="1">51.00 (28.00&#x2013;77.00)</td>
                  <td align="center" rowspan="1" colspan="1">0.462</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="t005fn001">
              <p>P-CgA, plasma chromogranin A; dU-5-HIAA, 24 h urine 5-hydroxyindoleacetic acid; Classes T-, N- and M refer to Tumor, Node and Metastasis of the TNM-staging system.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <table-wrap position="float" id="pone.0302813.t006">
          <object-id pub-id-type="doi">10.1371/journal.pone.0302813.t006</object-id>
          <label>Table 6</label>
          <caption>
            <title>Baseline characteristics and comparison stratified by Toll-like receptor (TLR) 6 cytoplasmic intensity in primary tumors and lymph node metastases.</title>
          </caption>
          <alternatives>
            <graphic xlink:href="pone.0302813.t006" id="pone.0302813.t006g" position="float"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="center" rowspan="1" colspan="1">Variables</th>
                  <th align="left" rowspan="1" colspan="1">TLR6 primary tumor cytoplasmic intensity<break/>low, <italic toggle="yes">n</italic> = <italic toggle="yes">74</italic></th>
                  <th align="center" rowspan="1" colspan="1">TLR6 primary tumor cytoplasmic intensity<break/>high, <italic toggle="yes">n</italic> = <italic toggle="yes">41</italic></th>
                  <th align="center" rowspan="1" colspan="1">P between groups</th>
                  <th align="center" rowspan="1" colspan="1">TLR6 metastasis cytoplasmic intensity<break/>low, <italic toggle="yes">n</italic> = <italic toggle="yes">53</italic></th>
                  <th align="center" rowspan="1" colspan="1">TLR6 metastasis cytoplasmic intensity<break/>high, <italic toggle="yes">n</italic> = 23</th>
                  <th align="center" rowspan="1" colspan="1">P between groups</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Sex</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.135</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.481</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Male, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">45 (60.8)</td>
                  <td align="center" rowspan="1" colspan="1">19 (46.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">30 (56.6)</td>
                  <td align="center" rowspan="1" colspan="1">11 (47.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Female, n (%)</td>
                  <td align="center" rowspan="1" colspan="1">29 (39.2)</td>
                  <td align="center" rowspan="1" colspan="1">22 (53.7)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">23 (43.4)</td>
                  <td align="center" rowspan="1" colspan="1">12 (52.2)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1"><bold>Age, median (IQR)</bold> years</td>
                  <td align="center" rowspan="1" colspan="1">65.55 (54.26&#x2013;73.13)</td>
                  <td align="center" rowspan="1" colspan="1">65.23 (57.64&#x2013;73.08)</td>
                  <td align="center" rowspan="1" colspan="1">0.898</td>
                  <td align="center" rowspan="1" colspan="1">66.51 (55.54&#x2013;71.85)</td>
                  <td align="center" rowspan="1" colspan="1">65.23 (56.27&#x2013;69.90)</td>
                  <td align="center" rowspan="1" colspan="1">0.591</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>T-Class</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.261</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.097</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">T1&#x2013;2, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">23 (31.1)</td>
                  <td align="center" rowspan="1" colspan="1">7 (17.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">15 (28.3)</td>
                  <td align="center" rowspan="1" colspan="1">2 (8.7)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">T3, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">30 (40.5)</td>
                  <td align="center" rowspan="1" colspan="1">20 (48.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">25 (47.2)</td>
                  <td align="center" rowspan="1" colspan="1">11 (47.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">T4, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">21 (28.4)</td>
                  <td align="center" rowspan="1" colspan="1">14 (34.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">13 (24.5)</td>
                  <td align="center" rowspan="1" colspan="1">10 (43.5)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>N-Class</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.790</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">N0, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">16 (21.6)</td>
                  <td align="center" rowspan="1" colspan="1">8 (19.5)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">N1&#x2013;2, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">58 (78.4)</td>
                  <td align="center" rowspan="1" colspan="1">33 (80.5)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>M-Class</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.511</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.908</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">M0, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">46 (62.2)</td>
                  <td align="center" rowspan="1" colspan="1">28 (68.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">33 (62.3)</td>
                  <td align="center" rowspan="1" colspan="1">14 (60.9)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">M1, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">28 (37.8)</td>
                  <td align="center" rowspan="1" colspan="1">13 (31.7)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">20 (37.7)</td>
                  <td align="center" rowspan="1" colspan="1">9 (39.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Stage</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.741</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.908</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">I&#x2013;II, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">10 (13.5)</td>
                  <td align="center" rowspan="1" colspan="1">5 (12.2)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0</td>
                  <td align="center" rowspan="1" colspan="1">0</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">III, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">36 (48.6)</td>
                  <td align="center" rowspan="1" colspan="1">23 (56.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">33 (62.3)</td>
                  <td align="center" rowspan="1" colspan="1">14 (60.9)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">IV, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">28 (37.8)</td>
                  <td align="center" rowspan="1" colspan="1">13 (35.7)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">20 (37.7)</td>
                  <td align="center" rowspan="1" colspan="1">9 (39.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Grade</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.784</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.903</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">1, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">57 (79.2)</td>
                  <td align="center" rowspan="1" colspan="1">30 (76.9)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">37 (72.5)</td>
                  <td align="center" rowspan="1" colspan="1">17 (73.9)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">2, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">15 (20.8)</td>
                  <td align="center" rowspan="1" colspan="1">9 (23.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">14 (27.5)</td>
                  <td align="center" rowspan="1" colspan="1">6 (26.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Tumor location</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.221</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.906</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Jejunum, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">3 (4.1)</td>
                  <td align="center" rowspan="1" colspan="1">4 (9.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">2 (3.8)</td>
                  <td align="center" rowspan="1" colspan="1">1 (4.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Ileum, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">71 (95.9)</td>
                  <td align="center" rowspan="1" colspan="1">37 (90.2)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">51 (96.2)</td>
                  <td align="center" rowspan="1" colspan="1">22 (95.7)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Somatostatin analogue treatment</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.059</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.288</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Yes, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">46 (62.2)</td>
                  <td align="center" rowspan="1" colspan="1">18 (43.9)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">30 (56.6)</td>
                  <td align="center" rowspan="1" colspan="1">16 (69.6)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Chemotherapy</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.486</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.638</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">No, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">63 (85.1)</td>
                  <td align="center" rowspan="1" colspan="1">34 (82.9)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">44 (83.0)</td>
                  <td align="center" rowspan="1" colspan="1">20 (87.0)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Preoperative, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">2 (2.7)</td>
                  <td align="center" rowspan="1" colspan="1">3 (7.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">1 (1.9)</td>
                  <td align="center" rowspan="1" colspan="1">1 (4.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Postoperative, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">9 (12.2)</td>
                  <td align="center" rowspan="1" colspan="1">4 (9.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">8 (15.1)</td>
                  <td align="center" rowspan="1" colspan="1">2 (8.7)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Multiple primary tumors</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.890</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.174</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Yes, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">21 (28.8)</td>
                  <td align="center" rowspan="1" colspan="1">12 (30.0)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">17 (32.7)</td>
                  <td align="center" rowspan="1" colspan="1">4 (17.4)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>P-CgA</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Median (IQR) nmol/L</td>
                  <td align="center" rowspan="1" colspan="1">6.40 (3.90&#x2013;15.50)</td>
                  <td align="center" rowspan="1" colspan="1">5.80 (3.20&#x2013;14.50)</td>
                  <td align="center" rowspan="1" colspan="1">0.524</td>
                  <td align="center" rowspan="1" colspan="1">6.50 (3.90&#x2013;14.00)</td>
                  <td align="center" rowspan="1" colspan="1">6.40 (3.10&#x2013;13.50)</td>
                  <td align="center" rowspan="1" colspan="1">0.499</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>dU-5-HIAA</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Median (IQR) &#x3BC;mol/L</td>
                  <td align="center" rowspan="1" colspan="1">46.00 (23.50&#x2013;198.50)</td>
                  <td align="center" rowspan="1" colspan="1">92.00 (37.00&#x2013;133.00)</td>
                  <td align="center" rowspan="1" colspan="1">0.312</td>
                  <td align="center" rowspan="1" colspan="1">76.50 (35.75&#x2013;196.00)</td>
                  <td align="center" rowspan="1" colspan="1">76.00 (44.00&#x2013;199.00)</td>
                  <td align="center" rowspan="1" colspan="1">0.808</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="t006fn001">
              <p>P-CgA, plasma chromogranin A; dU-5-HIAA, 24 h urine 5-hydroxyindoleacetic acid; Classes T-, N- and M refer to Tumor, Node and Metastasis of the TNM-staging system.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <table-wrap position="float" id="pone.0302813.t007">
          <object-id pub-id-type="doi">10.1371/journal.pone.0302813.t007</object-id>
          <label>Table 7</label>
          <caption>
            <title>Baseline characteristics and comparison stratified by Toll-like receptor (TLR) 7 cytoplasmic intensity in primary tumors and lymph node metastases.</title>
          </caption>
          <alternatives>
            <graphic xlink:href="pone.0302813.t007" id="pone.0302813.t007g" position="float"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="center" rowspan="1" colspan="1">Variables</th>
                  <th align="left" rowspan="1" colspan="1">TLR7 primary tumor cytoplasmic intensity<break/>low, <italic toggle="yes">n</italic> = <italic toggle="yes">74</italic></th>
                  <th align="center" rowspan="1" colspan="1">TLR7 primary tumor cytoplasmic intensity<break/>high, <italic toggle="yes">n</italic> = <italic toggle="yes">37</italic></th>
                  <th align="center" rowspan="1" colspan="1">P between groups</th>
                  <th align="center" rowspan="1" colspan="1">TLR7 metastasis cytoplasmic intensity<break/>low, <italic toggle="yes">n</italic> = <italic toggle="yes">46</italic></th>
                  <th align="center" rowspan="1" colspan="1">TLR7 metastasis cytoplasmic intensity<break/>high, <italic toggle="yes">n</italic> = 26</th>
                  <th align="center" rowspan="1" colspan="1">P between groups</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Sex</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.892</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.594</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Male, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">41 (55.4)</td>
                  <td align="center" rowspan="1" colspan="1">21 (56.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">26 (56.5)</td>
                  <td align="center" rowspan="1" colspan="1">13 (50.0</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Female, n (%)</td>
                  <td align="center" rowspan="1" colspan="1">33 (44.6)</td>
                  <td align="center" rowspan="1" colspan="1">16 (43.2)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">20 (43.5)</td>
                  <td align="center" rowspan="1" colspan="1">13 (50.0)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1"><bold>Age, median (IQR)</bold> years</td>
                  <td align="center" rowspan="1" colspan="1">65.35 (52.04&#x2013;73.74)</td>
                  <td align="center" rowspan="1" colspan="1">65.23 (58.83&#x2013;69.46)</td>
                  <td align="center" rowspan="1" colspan="1">0.798</td>
                  <td align="center" rowspan="1" colspan="1">67.03 (55.41&#x2013;72.29)</td>
                  <td align="center" rowspan="1" colspan="1">65.80 (57.82&#x2013;74.30)</td>
                  <td align="center" rowspan="1" colspan="1">0.622</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>T-Class</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.741</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">
<bold>0.049</bold>
</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">T1&#x2013;2, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">21 (28.4)</td>
                  <td align="center" rowspan="1" colspan="1">8 (21.6)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">15 (32.6)</td>
                  <td align="center" rowspan="1" colspan="1">2 (7.7)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">T3, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">30 (40.5)</td>
                  <td align="center" rowspan="1" colspan="1">16 (43.2)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">19 (41.3)</td>
                  <td align="center" rowspan="1" colspan="1">13 (50.0)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">T4, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">23 (31.1)</td>
                  <td align="center" rowspan="1" colspan="1">13 (35.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">12 (26.1)</td>
                  <td align="center" rowspan="1" colspan="1">11 (42.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>N-Class</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.239</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">N0, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">17 (23.0)</td>
                  <td align="center" rowspan="1" colspan="1">5 (13.5)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">N1&#x2013;2, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">57 (77.0)</td>
                  <td align="center" rowspan="1" colspan="1">32 (86.5)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>M-Class</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.576</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.899</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">M0, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">46 (62.2)</td>
                  <td align="center" rowspan="1" colspan="1">25 (67.6)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">29 (63.0)</td>
                  <td align="center" rowspan="1" colspan="1">16 (61.5)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">M1, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">28 (37.8)</td>
                  <td align="center" rowspan="1" colspan="1">12 (32.4)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">17 (37.0)</td>
                  <td align="center" rowspan="1" colspan="1">10 (38.5)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Stage</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.505</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.899</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">I&#x2013;II, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">10 (13.5)</td>
                  <td align="center" rowspan="1" colspan="1">3 (8.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0</td>
                  <td align="center" rowspan="1" colspan="1">0</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">III, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">36 (48.6)</td>
                  <td align="center" rowspan="1" colspan="1">22 (59.5)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">29 (63.0)</td>
                  <td align="center" rowspan="1" colspan="1">16 (61.5)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">IV, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">28 (37.8)</td>
                  <td align="center" rowspan="1" colspan="1">12 (32.4)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">17 (37.0)</td>
                  <td align="center" rowspan="1" colspan="1">10 (38.5)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Grade</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.947</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">1, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">58 (79.5)</td>
                  <td align="center" rowspan="1" colspan="1">28 (80.0)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">33 (75.0)</td>
                  <td align="center" rowspan="1" colspan="1">19 (73.1)</td>
                  <td align="center" rowspan="1" colspan="1">0.859</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">2, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">15 (20.5)</td>
                  <td align="center" rowspan="1" colspan="1">7 (20.0)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">11 (25.0)</td>
                  <td align="center" rowspan="1" colspan="1">7 (26.9)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Tumor location</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">
<bold>0.027</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.183</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Jejunum, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">2 (2.7)</td>
                  <td align="center" rowspan="1" colspan="1">5 (13.5)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">3 (6.5)</td>
                  <td align="center" rowspan="1" colspan="1">0</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Ileum, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">72 (93.7)</td>
                  <td align="center" rowspan="1" colspan="1">32 (86.5)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">43 (93.5)</td>
                  <td align="center" rowspan="1" colspan="1">26 (100)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Somatostatin analogue treatment</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.280</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.655</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Yes, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">44 (59.5)</td>
                  <td align="center" rowspan="1" colspan="1">18 (48.6)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">29 (63.0)</td>
                  <td align="center" rowspan="1" colspan="1">15 (57.7)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Chemotherapy</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">
<bold>0.048</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.733</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">No, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">64 (86.5)</td>
                  <td align="center" rowspan="1" colspan="1">31 (83.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">39 (84.8)</td>
                  <td align="center" rowspan="1" colspan="1">23 (88.5)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Preoperative, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">1 (1.4)</td>
                  <td align="center" rowspan="1" colspan="1">4 (10.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">1 (2.2)</td>
                  <td align="center" rowspan="1" colspan="1">1 (3.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Postoperative, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">9 (12.2 =</td>
                  <td align="center" rowspan="1" colspan="1">2 (5.4)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">6 (13.0)</td>
                  <td align="center" rowspan="1" colspan="1">2 (7.7)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Multiple primary tumors</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.967</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.594</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Yes, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">20 (27.4)</td>
                  <td align="center" rowspan="1" colspan="1">10 (27.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">13 (28.9)</td>
                  <td align="center" rowspan="1" colspan="1">6 (23.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>P-CgA</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Median (IQR) nmol/L</td>
                  <td align="center" rowspan="1" colspan="1">6.3 (3.75&#x2013;15.75)</td>
                  <td align="center" rowspan="1" colspan="1">6.60 (3.10&#x2013;12.00)</td>
                  <td align="center" rowspan="1" colspan="1">0.689</td>
                  <td align="center" rowspan="1" colspan="1">6.40 (4.00&#x2013;10.00)</td>
                  <td align="center" rowspan="1" colspan="1">3.95 (3.10&#x2013;18.75)</td>
                  <td align="center" rowspan="1" colspan="1">0.440</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>dU-5-HIAA</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Median (IQR) &#x3BC;mol/L</td>
                  <td align="center" rowspan="1" colspan="1">46.00 (23.50&#x2013;144.50)</td>
                  <td align="center" rowspan="1" colspan="1">95.50 (37.75&#x2013;221.50)</td>
                  <td align="center" rowspan="1" colspan="1">0.144</td>
                  <td align="center" rowspan="1" colspan="1">76.00 (40.00&#x2013;169.00)</td>
                  <td align="center" rowspan="1" colspan="1">67.00 (28.00&#x2013;339.50)</td>
                  <td align="center" rowspan="1" colspan="1">0.841</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="t007fn001">
              <p>P-CgA, plasma chromogranin A; dU-5-HIAA, 24 h urine 5-hydroxyindoleacetic acid; Classes T-, N- and M refer to Tumor, Node and Metastasis of the TNM-staging system.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <table-wrap position="float" id="pone.0302813.t008">
          <object-id pub-id-type="doi">10.1371/journal.pone.0302813.t008</object-id>
          <label>Table 8</label>
          <caption>
            <title>Baseline characteristics and comparison stratified by Toll-like receptor (TLR) 8 cytoplasmic intensity in primary tumors and lymph node metastases.</title>
          </caption>
          <alternatives>
            <graphic xlink:href="pone.0302813.t008" id="pone.0302813.t008g" position="float"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="center" rowspan="1" colspan="1">Variables</th>
                  <th align="left" rowspan="1" colspan="1">TLR8 primary tumor cytoplasmic intensity<break/>low, <italic toggle="yes">n</italic> = <italic toggle="yes">79</italic></th>
                  <th align="center" rowspan="1" colspan="1">TLR8 primary tumor cytoplasmic intensity<break/>high, <italic toggle="yes">n</italic> = <italic toggle="yes">34</italic></th>
                  <th align="center" rowspan="1" colspan="1">P between groups</th>
                  <th align="center" rowspan="1" colspan="1">TLR8 metastasis cytoplasmic intensity<break/>low, <italic toggle="yes">n</italic> = <italic toggle="yes">40</italic></th>
                  <th align="center" rowspan="1" colspan="1">TLR8 metastasis cytoplasmic intensity<break/>high, <italic toggle="yes">n</italic> = 36</th>
                  <th align="center" rowspan="1" colspan="1">P between groups</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Sex</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.102</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.663</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Male, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">48 (60.8)</td>
                  <td align="center" rowspan="1" colspan="1">15 (44.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">22 (55.0)</td>
                  <td align="center" rowspan="1" colspan="1">18 (50.0)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Female, n (%)</td>
                  <td align="center" rowspan="1" colspan="1">31 (39.2)</td>
                  <td align="center" rowspan="1" colspan="1">19 (55.9)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">18 (45.0)</td>
                  <td align="center" rowspan="1" colspan="1">18 (50.0)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1"><bold>Age, median (IQR)</bold> years</td>
                  <td align="center" rowspan="1" colspan="1">65.23 (54.20&#x2013;72.19)</td>
                  <td align="center" rowspan="1" colspan="1">67.36 (56.69&#x2013;73.44)</td>
                  <td align="center" rowspan="1" colspan="1">0.499</td>
                  <td align="center" rowspan="1" colspan="1">68.75 (55.51&#x2013;75.04)</td>
                  <td align="center" rowspan="1" colspan="1">65.43 (57.14&#x2013;69.38)</td>
                  <td align="center" rowspan="1" colspan="1">0.344</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>T-Class</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.867</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.119</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">T1&#x2013;2, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">20 (25.3)</td>
                  <td align="center" rowspan="1" colspan="1">10 (29.4)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">10 (25.0)</td>
                  <td align="center" rowspan="1" colspan="1">6 (16.7)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">T3, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">34 (43.0)</td>
                  <td align="center" rowspan="1" colspan="1">13 (38.2)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">22 (55.0)</td>
                  <td align="center" rowspan="1" colspan="1">15 (41.7)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">T4, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">25 (31.6)</td>
                  <td align="center" rowspan="1" colspan="1">11 (32.4)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">8 (20.0)</td>
                  <td align="center" rowspan="1" colspan="1">15 (41.7)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>N-Class</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.218</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">N0, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">13 (16.5)</td>
                  <td align="center" rowspan="1" colspan="1">9 (26.5)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">N1&#x2013;2, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">66 (83.5)</td>
                  <td align="center" rowspan="1" colspan="1">25 (73.5)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>M-Class</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.563</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.727</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">M0, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">51 (64.6)</td>
                  <td align="center" rowspan="1" colspan="1">20 (58.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">24 (60.0)</td>
                  <td align="center" rowspan="1" colspan="1">23 (63.9)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">M1, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">28 (35.4)</td>
                  <td align="center" rowspan="1" colspan="1">14 (41.2)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">16 (40.0)</td>
                  <td align="center" rowspan="1" colspan="1">13 (36.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Stage</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.772</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.727</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">I&#x2013;II, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">8 (10.1)</td>
                  <td align="center" rowspan="1" colspan="1">4 (11.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0</td>
                  <td align="center" rowspan="1" colspan="1">0</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">III, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">43 (54.4)</td>
                  <td align="center" rowspan="1" colspan="1">16 (47.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">24 (60.0)</td>
                  <td align="center" rowspan="1" colspan="1">23 (63.9)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">IV, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">28 (35.4)</td>
                  <td align="center" rowspan="1" colspan="1">14 (41.2)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">16 (40.0)</td>
                  <td align="center" rowspan="1" colspan="1">13 (36.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Grade</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.993</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.921</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">1, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">61 (78.2)</td>
                  <td align="center" rowspan="1" colspan="1">25 (78.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">29 (72.5)</td>
                  <td align="center" rowspan="1" colspan="1">25 (73.5)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">2, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">17 (21.8)</td>
                  <td align="center" rowspan="1" colspan="1">7 (21.9)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">11 (27.5)</td>
                  <td align="center" rowspan="1" colspan="1">9 (26.5)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Tumor location</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.859</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.619</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Jejunum, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">4 (5.1)</td>
                  <td align="center" rowspan="1" colspan="1">2 (5.9)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">2 (5.0)</td>
                  <td align="center" rowspan="1" colspan="1">1 (2.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Ileum, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">75 (94.9)</td>
                  <td align="center" rowspan="1" colspan="1">32 (94.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">38 (95.0)</td>
                  <td align="center" rowspan="1" colspan="1">35 (97.2)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Somatostatin analogue treatment</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.758</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">
<bold>0.048</bold>
</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Yes, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">44 (55.7)</td>
                  <td align="center" rowspan="1" colspan="1">20 (58.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">20 (50.0)</td>
                  <td align="center" rowspan="1" colspan="1">26 (72.2)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Chemotherapy</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.892</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.881</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">No, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">67 (84.8)</td>
                  <td align="center" rowspan="1" colspan="1">30 (88.2)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">33 (82.5)</td>
                  <td align="center" rowspan="1" colspan="1">31 (86.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Preoperative, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">3 (3.8)</td>
                  <td align="center" rowspan="1" colspan="1">1 (2.9)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">1 (2.5)</td>
                  <td align="center" rowspan="1" colspan="1">1 (2.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Postoperative, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">9 (11.4)</td>
                  <td align="center" rowspan="1" colspan="1">3 (8.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">6 (15.0)</td>
                  <td align="center" rowspan="1" colspan="1">4 (11.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Multiple primary tumors</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.824</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.776</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Yes, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">22 (28.2)</td>
                  <td align="center" rowspan="1" colspan="1">10 (30.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">12 (30.8)</td>
                  <td align="center" rowspan="1" colspan="1">10 (27.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>P-CgA</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Median (IQR) nmol/L</td>
                  <td align="center" rowspan="1" colspan="1">6.35 (3.475&#x2013;16.00)</td>
                  <td align="center" rowspan="1" colspan="1">7.00 (3.975&#x2013;20.25)</td>
                  <td align="center" rowspan="1" colspan="1">0.379</td>
                  <td align="center" rowspan="1" colspan="1">5.80 (3.650&#x2013;12.00)</td>
                  <td align="center" rowspan="1" colspan="1">6.30 (3.30&#x2013;15.00)</td>
                  <td align="center" rowspan="1" colspan="1">0.839</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>dU-5-HIAA</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Median (IQR) &#x3BC;mol/L</td>
                  <td align="center" rowspan="1" colspan="1">76.00 (28.00&#x2013;198.00)</td>
                  <td align="center" rowspan="1" colspan="1">43.00 (21.50&#x2013;180.750)</td>
                  <td align="center" rowspan="1" colspan="1">0.350</td>
                  <td align="center" rowspan="1" colspan="1">78.00 (38.00&#x2013;198.00)</td>
                  <td align="center" rowspan="1" colspan="1">57.00 (31.50&#x2013;187.50)</td>
                  <td align="center" rowspan="1" colspan="1">0.711</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="t008fn001">
              <p>P-CgA, plasma chromogranin A; dU-5-HIAA, 24 h urine 5-hydroxyindoleacetic acid; Classes T-, N- and M refer to Tumor, Node and Metastasis of the TNM-staging system.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <table-wrap position="float" id="pone.0302813.t009">
          <object-id pub-id-type="doi">10.1371/journal.pone.0302813.t009</object-id>
          <label>Table 9</label>
          <caption>
            <title>Baseline characteristics and comparison stratified by Toll-like receptor (TLR) 9 cytoplasmic intensity in primary tumors and lymph node metastases.</title>
          </caption>
          <alternatives>
            <graphic xlink:href="pone.0302813.t009" id="pone.0302813.t009g" position="float"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="center" rowspan="1" colspan="1">Variables</th>
                  <th align="left" rowspan="1" colspan="1">TLR9 primary tumor cytoplasmic intensity<break/>low, <italic toggle="yes">n</italic> = <italic toggle="yes">89</italic></th>
                  <th align="center" rowspan="1" colspan="1">TLR9 primary tumor cytoplasmic intensity<break/>high, <italic toggle="yes">n</italic> = <italic toggle="yes">22</italic></th>
                  <th align="center" rowspan="1" colspan="1">P between groups</th>
                  <th align="center" rowspan="1" colspan="1">TLR9 metastasis cytoplasmic intensity<break/>low, <italic toggle="yes">n</italic> = <italic toggle="yes">54</italic></th>
                  <th align="center" rowspan="1" colspan="1">TLR9 metastasis cytoplasmic intensity<break/>high, <italic toggle="yes">n</italic> = 16</th>
                  <th align="center" rowspan="1" colspan="1">P between groups</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Sex</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.412</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.857</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Male, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">48 (53.9)</td>
                  <td align="center" rowspan="1" colspan="1">14 (63.6)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">29 (53.7)</td>
                  <td align="center" rowspan="1" colspan="1">9 (56.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Female, n (%)</td>
                  <td align="center" rowspan="1" colspan="1">41 (46.1)</td>
                  <td align="center" rowspan="1" colspan="1">8 (36.4)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">25 (46.3)</td>
                  <td align="center" rowspan="1" colspan="1">7 (43.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1"><bold>Age, median (IQR)</bold> years</td>
                  <td align="center" rowspan="1" colspan="1">61.34 (53.43&#x2013;71.52)</td>
                  <td align="center" rowspan="1" colspan="1">69.46 (65.84&#x2013;73.75)</td>
                  <td align="center" rowspan="1" colspan="1">
<bold>0.012</bold>
</td>
                  <td align="center" rowspan="1" colspan="1">65.55 (56.13&#x2013;70.54)</td>
                  <td align="center" rowspan="1" colspan="1">58.83 (45.01&#x2013;74.48)</td>
                  <td align="center" rowspan="1" colspan="1">0.467</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>T-Class</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.470</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.192</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">T1&#x2013;2, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">24 (27.0)</td>
                  <td align="center" rowspan="1" colspan="1">4 (18.2)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">10 (18.5)</td>
                  <td align="center" rowspan="1" colspan="1">5 (31.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">T3, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">36 (40.4)</td>
                  <td align="center" rowspan="1" colspan="1">12 (54.5)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">25 (46.3)</td>
                  <td align="center" rowspan="1" colspan="1">9 (56.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">T4, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">29 (32.6)</td>
                  <td align="center" rowspan="1" colspan="1">6 (27.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">19 (35.2)</td>
                  <td align="center" rowspan="1" colspan="1">2 (12.5)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>N-Class</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.224</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">N0, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">18 (20.2)</td>
                  <td align="center" rowspan="1" colspan="1">2 (9.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">N1&#x2013;2, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">71 (79.8)</td>
                  <td align="center" rowspan="1" colspan="1">20 (90.9)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>M-Class</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.950</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.252</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">M0, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">56 (62.9)</td>
                  <td align="center" rowspan="1" colspan="1">14 (63.6)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">32 (59.3)</td>
                  <td align="center" rowspan="1" colspan="1">12 (75.0)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">M1, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">33 (37.1)</td>
                  <td align="center" rowspan="1" colspan="1">8 (36.4)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">22 (40.7)</td>
                  <td align="center" rowspan="1" colspan="1">4 (25.0)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Stage</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.537</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.252</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">I&#x2013;II, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">11 (12.4)</td>
                  <td align="center" rowspan="1" colspan="1">1 (4.5)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0</td>
                  <td align="center" rowspan="1" colspan="1">0</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">III, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">45 (50.6)</td>
                  <td align="center" rowspan="1" colspan="1">13 (59.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">32 (59.3)</td>
                  <td align="center" rowspan="1" colspan="1">12 (75.0)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">IV, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">33 (37.1)</td>
                  <td align="center" rowspan="1" colspan="1">8 (36.4)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">22 (40.7)</td>
                  <td align="center" rowspan="1" colspan="1">4 (25.0)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Grade</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.436</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.187</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">1, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">69 (79.3)</td>
                  <td align="center" rowspan="1" colspan="1">15 (71.4)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">41 (78.8)</td>
                  <td align="center" rowspan="1" colspan="1">10 (62.5)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">2, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">18 (20.7)</td>
                  <td align="center" rowspan="1" colspan="1">6 (28.6)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">11 (21.2)</td>
                  <td align="center" rowspan="1" colspan="1">6 (37.5)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Tumor location</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.247</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.659</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Jejunum, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">3 (3.4)</td>
                  <td align="center" rowspan="1" colspan="1">2 (9.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">2 (3.7)</td>
                  <td align="center" rowspan="1" colspan="1">1 (6.2)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Ileum, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">86 (96.6)</td>
                  <td align="center" rowspan="1" colspan="1">20 (90.9)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">52 (96.3)</td>
                  <td align="center" rowspan="1" colspan="1">15 (93.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Somatostatin analogue treatment</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.475</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.865</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Yes, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">52 (58.4)</td>
                  <td align="center" rowspan="1" colspan="1">11 (50.0)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">35 (64.8)</td>
                  <td align="center" rowspan="1" colspan="1">10 (62.5)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Chemotherapy</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.930</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.446</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">No, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">76 (85.4)</td>
                  <td align="center" rowspan="1" colspan="1">19 (86.4)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">47 (87.0)</td>
                  <td align="center" rowspan="1" colspan="1">13 (81.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Preoperative, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">3 (3.4)</td>
                  <td align="center" rowspan="1" colspan="1">1 (4.5)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">2 (3.7)</td>
                  <td align="center" rowspan="1" colspan="1">0</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Postoperative, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">10 (11.2)</td>
                  <td align="center" rowspan="1" colspan="1">2 (9.1)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">5 (9.3)</td>
                  <td align="center" rowspan="1" colspan="1">3 (18.8)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>Multiple primary tumors</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.445</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">0.936</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Yes, <italic toggle="yes">n</italic> (%)</td>
                  <td align="center" rowspan="1" colspan="1">27 (31.0)</td>
                  <td align="center" rowspan="1" colspan="1">5 (22.7)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">16 (30.2)</td>
                  <td align="center" rowspan="1" colspan="1">5 (31.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>P-CgA</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Median (IQR) nmol/L</td>
                  <td align="center" rowspan="1" colspan="1">6.30 (3.60&#x2013;14.00)</td>
                  <td align="center" rowspan="1" colspan="1">4.70 (3.00&#x2013;36.00)</td>
                  <td align="center" rowspan="1" colspan="1">0.702</td>
                  <td align="center" rowspan="1" colspan="1">6.30 (3.60&#x2013;14.00)</td>
                  <td align="center" rowspan="1" colspan="1">5.00 (3.00&#x2013;14.00)</td>
                  <td align="center" rowspan="1" colspan="1">0.527</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>dU-5-HIAA</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Median (IQR) &#x3BC;mol/L</td>
                  <td align="center" rowspan="1" colspan="1">43.00 (25.00&#x2013;164.25)</td>
                  <td align="center" rowspan="1" colspan="1">122.00 (92.00&#x2013;269.50)</td>
                  <td align="center" rowspan="1" colspan="1">
<bold>0.004</bold>
</td>
                  <td align="center" rowspan="1" colspan="1">68.00 (40.00&#x2013;198.00)</td>
                  <td align="center" rowspan="1" colspan="1">112.00 (25.00&#x2013;187.50)</td>
                  <td align="center" rowspan="1" colspan="1">0.839</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="t009fn001">
              <p>P-CgA, plasma chromogranin A; dU-5-HIAA, 24 h urine 5-hydroxyindoleacetic acid; Classes T-, N- and M refer to Tumor, Node and Metastasis of the TNM-staging system.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="sec009">
        <title>Staining</title>
        <p>Cytoplasmic staining was observed with TLRs 1&#x2013;2 and 4&#x2013;9. Nucleic staining was observed with TLR5. Staining examples are shown in <xref rid="pone.0302813.g001" ref-type="fig">Fig 1</xref>. The only TLR showing completely negative staining despite external control being positive was TLR3. All stained cases were evaluated to have 100% staining. Median staining intensities are shown in <xref rid="pone.0302813.t010" ref-type="table">Table 10</xref>.</p>
        <fig position="float" id="pone.0302813.g001">
          <object-id pub-id-type="doi">10.1371/journal.pone.0302813.g001</object-id>
          <label>Fig 1</label>
          <caption>
            <title>Staining examples.</title>
            <p>Immunohistochemical staining examples of Toll-like receptors (TLRs) 1, 2, 4, 5, 6, 7, 8 and 9 in representative small bowel neuroendocrine tumor samples showing (<bold>A</bold>) High TLR1 cytoplasmic intensity, (<bold>B</bold>) intermediate TLR2 cytoplasmic intensity, (<bold>C</bold>) intermediate TLR4 cytoplasmic intensity, (<bold>D</bold>) high TLR5 cytoplasmic and nucleic intensity, (<bold>E</bold>) Intermediate TLR6 cytoplasmic intensity, (<bold>F</bold>) intermediate TLR7 cytoplasmic intensity, (<bold>G</bold>) high TLR8 cytoplasmic intensity and (<bold>H</bold>) intermediate TLR9 cytoplasmic intensity in x20 magnification. The scale bar length is 50 &#x3BC;m (bottom left corner). Arrows indicate TLR-positive tumor cell islets.</p>
          </caption>
          <graphic xlink:href="pone.0302813.g001" position="float"/>
        </fig>
        <table-wrap position="float" id="pone.0302813.t010">
          <object-id pub-id-type="doi">10.1371/journal.pone.0302813.t010</object-id>
          <label>Table 10</label>
          <caption>
            <title>Median Toll-like receptor (TLR) staining intensity in primary small bowel neuroendocrine tumors and lymph node metastases.</title>
          </caption>
          <alternatives>
            <graphic xlink:href="pone.0302813.t010" id="pone.0302813.t010g" position="float"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="center" rowspan="1" colspan="1"/>
                  <th align="center" rowspan="1" colspan="1">Primary tumors</th>
                  <th align="center" rowspan="1" colspan="1">Lymph node metastases</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>TLR1</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Cytoplasmic</td>
                  <td align="center" rowspan="1" colspan="1">2 (IQR 1.5&#x2013;2)</td>
                  <td align="center" rowspan="1" colspan="1">2 (IQR 1.5&#x2013;2)</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>TLR2</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Cytoplasmic</td>
                  <td align="center" rowspan="1" colspan="1">1.5 (IQR 1&#x2013;2)</td>
                  <td align="center" rowspan="1" colspan="1">1.5 (IQR 1.5&#x2013;2)</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>TLR4</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Cytoplasmic</td>
                  <td align="center" rowspan="1" colspan="1">1.5 (IQR 1&#x2013;2)</td>
                  <td align="center" rowspan="1" colspan="1">2 (IQR 1.5&#x2013;2.5)</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>TLR5</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Cytoplasmic</td>
                  <td align="center" rowspan="1" colspan="1">1.5 (IQR 1&#x2013;2.5)</td>
                  <td align="center" rowspan="1" colspan="1">2.5 (IQR 2&#x2013;2.5)</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Nucleic</td>
                  <td align="center" rowspan="1" colspan="1">1.5 (IQR 0&#x2013;2.5)</td>
                  <td align="center" rowspan="1" colspan="1">2.5 (IQR 2&#x2013;2.5)</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>TLR6</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Cytoplasmic</td>
                  <td align="center" rowspan="1" colspan="1">1 (IQR 1&#x2013;1.5)</td>
                  <td align="center" rowspan="1" colspan="1">1 (1&#x2013;1.5)</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>TLR7</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Cytoplasmic</td>
                  <td align="center" rowspan="1" colspan="1">1.5 (IQR 1&#x2013;2)</td>
                  <td align="center" rowspan="1" colspan="1">2 (IQR 1.5&#x2013;2.5)</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>TLR8</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Cytoplasmic</td>
                  <td align="center" rowspan="1" colspan="1">1.5 (IQR 1&#x2013;2)</td>
                  <td align="center" rowspan="1" colspan="1">1 (IQR 1&#x2013;2)</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
<bold>TLR9</bold>
</td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Cytoplasmic</td>
                  <td align="center" rowspan="1" colspan="1">2 (IQR 1&#x2013;2).</td>
                  <td align="center" rowspan="1" colspan="1">2 (IQR 1.5&#x2013;2).</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="t010fn001">
              <p>IQR, interquartile range.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="sec010">
        <title>Toll-like receptors and association with clinicopathological variables</title>
        <p>There was a significant difference in median age of the patients between low and high TLR4 cytoplasmic intensity in SB-NETs, patients being older in the latter group (58 years vs. 68 years, p = 0.002) (<xref rid="pone.0302813.t003" ref-type="table">Table 3</xref>). Similar finding was also true with SB-NET cytoplasmic TLR9 intensity (61 years vs. 69 years, p = 0.012) (<xref rid="pone.0302813.t009" ref-type="table">Table 9</xref>). A larger proportion of jejunal tumors was observed in SB-NETs with high nucleic TLR5 intensity group compared to low nucleic intensity (10.8% vs. 1.6%, p = 0.043) (<xref rid="pone.0302813.t005" ref-type="table">Table 5</xref>). Similar finding was also true with TLR7 in SB-NETs (13.5% vs 2.7%, p = 0.027) (<xref rid="pone.0302813.t007" ref-type="table">Table 7</xref>). A larger proportion of patients with high cytoplasmic TLR7 intensity in lymph node metastases tended to have high T-class (T3-4) compared to the low intensity group (p = 0.049) (<xref rid="pone.0302813.t007" ref-type="table">Table 7</xref>). Patients with high cytoplasmic TLR8 intensity in lymph node metastases had received more somatostatin analogue treatment compared to low intensity group (72.2% vs. 50.0%, p = 0.048) (<xref rid="pone.0302813.t008" ref-type="table">Table 8</xref>). Median urine 5-hydroxyindoleacetic acid (5-HIAA) levels were significantly higher in SB-NETs with high cytoplasmic TLR9 intensity compared with low intensity (122 &#x3BC;mol/L vs. 43 &#x3BC;mol/L, p = 0.004) (<xref rid="pone.0302813.t009" ref-type="table">Table 9</xref>).</p>
      </sec>
      <sec id="sec011">
        <title>Toll-like receptors and survival</title>
        <p>Disease-specific survival in the whole cohort at 5 years was 89%, at 10 years 75.6% and at the end of follow up 57.3%.</p>
        <p>None of the primary tumor TLR intensities associated with DSS. Although high cytoplasmic TLR8 intensity in primary tumors seemed to associate with worse survival compared with low intensity group (49.5% vs. 72.5%, p = 0.068), but the difference was not statistically significant. In lymph node metastasis, high TLR7 intensity was associated with significantly worse DSS compared to low intensity (26.4% vs. 84.9%, p = 0.028) (<xref rid="pone.0302813.g002" ref-type="fig">Fig 2</xref>). Survival percentages are presented in <xref rid="pone.0302813.t011" ref-type="table">Table 11</xref>.</p>
        <fig position="float" id="pone.0302813.g002">
          <object-id pub-id-type="doi">10.1371/journal.pone.0302813.g002</object-id>
          <label>Fig 2</label>
          <caption>
            <title>Kaplan-Meier curve.</title>
            <p>Cumulative disease-specific survival (DSS) in small bowel neuroendocrine tumor lymph node metastasis stratified by Toll like-receptor (TLR) 7 cytoplasmic staining intensity. The Kaplan-Meier curves for DSS differentiate between low and high TLR7 expression (p = 0.028).</p>
          </caption>
          <graphic xlink:href="pone.0302813.g002" position="float"/>
        </fig>
        <table-wrap position="float" id="pone.0302813.t011">
          <object-id pub-id-type="doi">10.1371/journal.pone.0302813.t011</object-id>
          <label>Table 11</label>
          <caption>
            <title>Disease-specific survival rates based on Toll-like receptor (TLR) 1, 2, 4, 5, 6, 7, 8, and 9 cytoplasmic staining intensity and TLR5 nucleic staining intensity in both primary tumors and lymph node metastases.</title>
          </caption>
          <alternatives>
            <graphic xlink:href="pone.0302813.t011" id="pone.0302813.t011g" position="float"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="center" rowspan="1" colspan="1">Disease-specific survival</th>
                  <th align="center" rowspan="1" colspan="1">No. of patients</th>
                  <th align="center" rowspan="1" colspan="1">TLR1<break/>cytoplasmic intensity, low</th>
                  <th align="center" rowspan="1" colspan="1">TLR1 cytoplasmic intensity, high</th>
                  <th align="center" rowspan="1" colspan="1">p</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Primary tumors</td>
                  <td align="center" rowspan="1" colspan="1">116</td>
                  <td align="center" rowspan="1" colspan="1">67.2%</td>
                  <td align="center" rowspan="1" colspan="1">54.1%</td>
                  <td align="center" rowspan="1" colspan="1">0.518</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Lymph node metastases</td>
                  <td align="center" rowspan="1" colspan="1">70</td>
                  <td align="center" rowspan="1" colspan="1">70.5%</td>
                  <td align="center" rowspan="1" colspan="1">33.3%</td>
                  <td align="center" rowspan="1" colspan="1">0.236</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">
<bold>No. of patients</bold>
</td>
                  <td align="center" rowspan="1" colspan="1">
<bold>TLR2 cytoplasmic intensity, low</bold>
</td>
                  <td align="center" rowspan="1" colspan="1">
<bold>TLR2 cytoplasmic intensity, high</bold>
</td>
                  <td align="center" rowspan="1" colspan="1">
<bold>p</bold>
</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Primary tumors</td>
                  <td align="center" rowspan="1" colspan="1">84</td>
                  <td align="center" rowspan="1" colspan="1">58.0%</td>
                  <td align="center" rowspan="1" colspan="1">68.1%</td>
                  <td align="center" rowspan="1" colspan="1">0.975</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Lymph node metastases</td>
                  <td align="center" rowspan="1" colspan="1">72</td>
                  <td align="center" rowspan="1" colspan="1">79.5%</td>
                  <td align="center" rowspan="1" colspan="1">70.4%</td>
                  <td align="center" rowspan="1" colspan="1">0.343</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">
<bold>No. of patients</bold>
</td>
                  <td align="center" rowspan="1" colspan="1">
<bold>TLR4 cytoplasmic intensity low</bold>
</td>
                  <td align="center" rowspan="1" colspan="1">
<bold>TLR4 cytoplasmic intensity, high</bold>
</td>
                  <td align="center" rowspan="1" colspan="1">
<bold>p</bold>
</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Primary tumors</td>
                  <td align="center" rowspan="1" colspan="1">116</td>
                  <td align="center" rowspan="1" colspan="1">64.2%</td>
                  <td align="center" rowspan="1" colspan="1">67.3%</td>
                  <td align="center" rowspan="1" colspan="1">0.956</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Lymph node metastases</td>
                  <td align="center" rowspan="1" colspan="1">77</td>
                  <td align="center" rowspan="1" colspan="1">68.5%</td>
                  <td align="center" rowspan="1" colspan="1">63.3</td>
                  <td align="center" rowspan="1" colspan="1">0.329</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">
<bold>No. of patients</bold>
</td>
                  <td align="center" rowspan="1" colspan="1">
<bold>TLR5 cytoplasmic intensity low</bold>
</td>
                  <td align="center" rowspan="1" colspan="1">
<bold>TLR5 cytoplasmic intensity, high</bold>
</td>
                  <td align="center" rowspan="1" colspan="1">
<bold>p</bold>
</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Primary tumors</td>
                  <td align="center" rowspan="1" colspan="1">99</td>
                  <td align="center" rowspan="1" colspan="1">64.4%</td>
                  <td align="center" rowspan="1" colspan="1">65.3%</td>
                  <td align="center" rowspan="1" colspan="1">0.497</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Lymph node metastases</td>
                  <td align="center" rowspan="1" colspan="1">58</td>
                  <td align="center" rowspan="1" colspan="1">67.3%</td>
                  <td align="center" rowspan="1" colspan="1">100%</td>
                  <td align="center" rowspan="1" colspan="1">0.363</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">
<bold>No. of patients</bold>
</td>
                  <td align="center" rowspan="1" colspan="1">
<bold>TLR5 nucleic intensity low</bold>
</td>
                  <td align="center" rowspan="1" colspan="1">
<bold>TLR5 nucleic intensity, high</bold>
</td>
                  <td align="center" rowspan="1" colspan="1">
<bold>p</bold>
</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Primary tumors</td>
                  <td align="center" rowspan="1" colspan="1">99</td>
                  <td align="center" rowspan="1" colspan="1">64.2%</td>
                  <td align="center" rowspan="1" colspan="1">64.8%</td>
                  <td align="center" rowspan="1" colspan="1">0.457</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Lymph node metastases</td>
                  <td align="center" rowspan="1" colspan="1">58</td>
                  <td align="center" rowspan="1" colspan="1">65.7%</td>
                  <td align="center" rowspan="1" colspan="1">84.6%</td>
                  <td align="center" rowspan="1" colspan="1">0.508</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">
<bold>No. of patients</bold>
</td>
                  <td align="center" rowspan="1" colspan="1">
<bold>TLR6 cytoplasmic intensity low</bold>
</td>
                  <td align="center" rowspan="1" colspan="1">
<bold>TLR6 cytoplasmic intensity, high</bold>
</td>
                  <td align="center" rowspan="1" colspan="1">
<bold>p</bold>
</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Primary tumors</td>
                  <td align="center" rowspan="1" colspan="1">115</td>
                  <td align="center" rowspan="1" colspan="1">65.6%</td>
                  <td align="center" rowspan="1" colspan="1">69.4%</td>
                  <td align="center" rowspan="1" colspan="1">0.701</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Lymph node metastases</td>
                  <td align="center" rowspan="1" colspan="1">76</td>
                  <td align="center" rowspan="1" colspan="1">68.7%</td>
                  <td align="center" rowspan="1" colspan="1">71.7%</td>
                  <td align="center" rowspan="1" colspan="1">0.803</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">
<bold>No. of patients</bold>
</td>
                  <td align="center" rowspan="1" colspan="1">
<bold>TLR7 cytoplasmic intensity low</bold>
</td>
                  <td align="center" rowspan="1" colspan="1">
<bold>TLR7 cytoplasmic intensity, high</bold>
</td>
                  <td align="center" rowspan="1" colspan="1">
<bold>p</bold>
</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Primary tumors</td>
                  <td align="center" rowspan="1" colspan="1">111</td>
                  <td align="center" rowspan="1" colspan="1">64.1%</td>
                  <td align="center" rowspan="1" colspan="1">75.7%</td>
                  <td align="center" rowspan="1" colspan="1">0.278</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Lymph node metastases</td>
                  <td align="center" rowspan="1" colspan="1">72</td>
                  <td align="center" rowspan="1" colspan="1">84.9%</td>
                  <td align="center" rowspan="1" colspan="1">26.4%</td>
                  <td align="center" rowspan="1" colspan="1">
<bold>0.028</bold>
</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">
<bold>No. of patients</bold>
</td>
                  <td align="center" rowspan="1" colspan="1">
<bold>TLR8 cytoplasmic intensity low</bold>
</td>
                  <td align="center" rowspan="1" colspan="1">
<bold>TLR8 cytoplasmic intensity, high</bold>
</td>
                  <td align="center" rowspan="1" colspan="1">
<bold>p</bold>
</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Primary tumors</td>
                  <td align="center" rowspan="1" colspan="1">113</td>
                  <td align="center" rowspan="1" colspan="1">72.5%</td>
                  <td align="center" rowspan="1" colspan="1">49.5%</td>
                  <td align="center" rowspan="1" colspan="1">0.068</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Lymph node metastases</td>
                  <td align="center" rowspan="1" colspan="1">76</td>
                  <td align="center" rowspan="1" colspan="1">69.3%</td>
                  <td align="center" rowspan="1" colspan="1">65.0%</td>
                  <td align="center" rowspan="1" colspan="1">0.727</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">
<bold>No. of patients</bold>
</td>
                  <td align="center" rowspan="1" colspan="1">
<bold>TLR9 cytoplasmic intensity low</bold>
</td>
                  <td align="center" rowspan="1" colspan="1">
<bold>TLR9 cytoplasmic intensity, high</bold>
</td>
                  <td align="center" rowspan="1" colspan="1">
<bold>p</bold>
</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Primary tumors</td>
                  <td align="center" rowspan="1" colspan="1">111</td>
                  <td align="center" rowspan="1" colspan="1">62.4%</td>
                  <td align="center" rowspan="1" colspan="1">71.4%</td>
                  <td align="center" rowspan="1" colspan="1">0.612</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Lymph node metastases</td>
                  <td align="center" rowspan="1" colspan="1">70</td>
                  <td align="center" rowspan="1" colspan="1">62.6%</td>
                  <td align="center" rowspan="1" colspan="1">87.5%</td>
                  <td align="center" rowspan="1" colspan="1">0.788</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
        </table-wrap>
        <p>Crude and adjusted HRs for disease specific mortality are presented in <xref rid="pone.0302813.t012" ref-type="table">Table 12</xref>. Adjusted HR in high cytoplasmic TLR7 lymph node metastasis intensity group was 3.90 (95% CI 1.07&#x2013;14.3) when compared to low intensity.</p>
        <table-wrap position="float" id="pone.0302813.t012">
          <object-id pub-id-type="doi">10.1371/journal.pone.0302813.t012</object-id>
          <label>Table 12</label>
          <caption>
            <title>Hazard ratios (HR) for disease-specific mortality with 95% confidence intervals (CI) in small bowel neuroendocrine tumor lymph node metastasis stratified by Toll-like receptor (TLR) 7 staining intensity (low/high).</title>
          </caption>
          <alternatives>
            <graphic xlink:href="pone.0302813.t012" id="pone.0302813.t012g" position="float"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="center" colspan="5" rowspan="1">TLR7 intensity</th>
                </tr>
                <tr>
                  <th align="center" rowspan="1" colspan="1">Lymph node metastasis</th>
                  <th align="center" rowspan="1" colspan="1">No. of patients</th>
                  <th align="center" rowspan="1" colspan="1">Low<break/>HR (95%CI)</th>
                  <th align="center" rowspan="1" colspan="1">High<break/>HR (95%CI)</th>
                  <th align="center" rowspan="1" colspan="1"/>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Crude</td>
                  <td align="center" rowspan="1" colspan="1">72</td>
                  <td align="center" rowspan="1" colspan="1">1.00 (reference)</td>
                  <td align="center" rowspan="1" colspan="1">3.90 (1.07&#x2013;14.3)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Adjusted</td>
                  <td align="center" rowspan="1" colspan="1">72</td>
                  <td align="center" rowspan="1" colspan="1">1.00 (reference)</td>
                  <td align="center" rowspan="1" colspan="1">7.45 (1.25&#x2013;44.5)</td>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="t012fn001">
              <p>Adjusted for age (continuous), sex (male/female), stage (I-II, III, IV), grade of differentiation (G1 or G2) and somatostatin therapy (no/yes).</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
    </sec>
    <sec sec-type="conclusions" id="sec012">
      <title>Discussion</title>
      <p>In the present study, we discovered TLR 1, 2, 4, 5, 6, 7, 8, and 9 expression in SB-NETs and lymph node metastases. High TLR7 intensity in lymph node metastases associated with worse survival both in univariate model and after adjusting for confounders. SB-NETs with high TLR8 expression had worse survival compared to low expression, but the difference was not statistically significant. TLRs 1, 2, 4, 5, 6, and 9 showed no association with survival.</p>
      <p>This study has several strengths. The present study was to our knowledge the first study to characterize the expression of TLRs in NETs overall, and specifically in SB-NETs. Our study included both samples from primary tumors and lymph node metastases for extended understanding of the subject in question. Our cohort included over a hundred patients, which is a large cohort in the field of NET research due to the slowly progressing nature and rarity of the disease. Many large studies today are done by tissue microarray techniques, but we were able to use whole section slides including selection of deepest invasion area. Our study has an extensive follow-up period which is of utmost importance when investigating diseases such as SB-NETs which have relatively slow disease progression. Finland is known for meticulous statistics, and we were provided with reliable and complete registry data by Statistics Finland considering both causes and times of death. This allowed for accurate DSS analyses. Our study also has limitations. The study population consisted only of G1 and G2 SB-NETs so the results cannot be applied to G3 SB-NETs or small bowel neuroendocrine carcinomas (SB-NECs). This is often the case with NET research due to the rarity and typically inoperable nature of G3/NEC disease, yet it leaves a gap in research knowledge when it comes to the most aggressive forms of this disease. The number of disease-specific deaths can be argued to be small, even though the follow-up period was extensive. The relatively small size of the cohort and small number of deaths create uncertainty to the results and replication studies are needed for more robust conclusions. The study is also limited by the different numbers of available samples per TLR. Some samples stained inconsistently and were excluded from the analyses, while others did not have adequate tissue material for all stainings. The hospitals also later limited the availability of new samples to preserve the diagnostic samples. Also since the study is exploratory, multiple statistical testing induces a risk of chance findings and confirmatory studies are deemed necessary.</p>
      <p>Previous NET studies have investigated TLRs mostly in Merkel cell carcinoma (MCC), an aggressive, rare neuroendocrine skin malignancy often caused by Merkel cell polyomavirus (MCV). A study by Jouhi et al characterized TLR 2, 4, 5, 7 and 9 expressions in 128 patients with MCC [<xref rid="pone.0302813.ref028" ref-type="bibr">28</xref>]. They found preliminary association with TLR expression and clinicopathological variables, such as MCV status (positive/negative), tumor size and patient age. Like their findings, we also found high TLR4 expression to correlate with older age. In 2023, Imon et al used computational formulation to create a multiepitope candidate vaccine against MCV, incorporating TLR4 agonist as an adjuvant for highest immune response activation [<xref rid="pone.0302813.ref029" ref-type="bibr">29</xref>]. The candidate vaccine was tested in silico, where it seemed to promote immune memory development and natural immune protection against MCV. A pilot study by Bhatia et al investigated intratumoral injections of G100, a TLR4 agonist, in patients with MCC [<xref rid="pone.0302813.ref030" ref-type="bibr">30</xref>]. The patients showed activation of pro-inflammatory changes, which associated with tumor regression. Sample size in the study was small and they found no correlation between clinical responses and baseline TLR expression. A study by Young et al analyzed 600 immune-related genes in pancreatic neuroendocrine tumors (PanNET), among them being TLR3 [<xref rid="pone.0302813.ref031" ref-type="bibr">31</xref>]. In Young&#x2019;s study, high TLR3 gene expression in a specific subtype of PanNET called metastasis-like primary (MLP)-1 was associated with poorer overall survival and the study also suggests that TLR3 may affect immune related gene expression and immune escape in MLP-1. The study also showed TLR7 gene enrichment in MLP-1 [<xref rid="pone.0302813.ref031" ref-type="bibr">31</xref>]. No further literature about TLRs in NETs could be found.</p>
      <p>The role of TLRs in other cancers is controversial. It seems that the anti- or protumor effects of TLRs depend on the TLR is question, the cancer type and the immune cells infiltrating the tumor [<xref rid="pone.0302813.ref023" ref-type="bibr">23</xref>]. A recent 2023 study by &#xC7;elik et al on breast cancer found high TLR9 expression to associate with invasive carcinoma and low expression to associate with increased overall survival [<xref rid="pone.0302813.ref032" ref-type="bibr">32</xref>]. TLR7 and TLR8 activation in non-small cell lung cancer induced survival of cancer cell lines and increased cancer cell chemoresistance [<xref rid="pone.0302813.ref033" ref-type="bibr">33</xref>]. In gastric cancer TLR4 and TLR5 activation induced cancer cell survival [<xref rid="pone.0302813.ref034" ref-type="bibr">34</xref>]. In esophageal cancer TLR3 was associated with invasion and lymph node metastasis, TLR4 with lymph node metastasis and TLR7 with worse histological grade [<xref rid="pone.0302813.ref035" ref-type="bibr">35</xref>]. In colorectal cancer, TLR2 expression may contribute to sporadic carcinogenesis and TLR4 may increase cancer cell survival [<xref rid="pone.0302813.ref034" ref-type="bibr">34</xref>]. In murine models, TLR 7/8 agonist R848 strengthened the antitumor effect of both oxaliplatin in colorectal cancer and of stereotactic body radiotherapy in pancreatic ductal adenocarcinoma [<xref rid="pone.0302813.ref036" ref-type="bibr">36</xref>,<xref rid="pone.0302813.ref037" ref-type="bibr">37</xref>]. While TLR 7/8 agonist seems to boost the antitumor effect of different treatments, according to a meta-analysis, high TLR7 expression in tumors seems to lead to worse survival in a number of cancers [<xref rid="pone.0302813.ref038" ref-type="bibr">38</xref>]. TLR7 agonists can also stimulate these TLR7-expressing tumor cells [<xref rid="pone.0302813.ref039" ref-type="bibr">39</xref>].</p>
      <p>TLR4 expression has been associated with advanced stage and poor prognosis in esophageal adenocarcinoma. Also, TLR 1/2/6 -network was shown to be upregulated in Barrett&#x2019;s metaplasia, esophageal dysplasia and esophageal cancer. [<xref rid="pone.0302813.ref040" ref-type="bibr">40</xref>]. The significance of luminal pathogen sensing TLRs in the esophagus may be related to the passage and direct contact of microbial material with luminal epithelial cells. The cancer cells in SB-NETs are not directly in contact with the bowel lumen. Although some bacteria may pass through the mucosa, we speculate SB-NETs to have less contact with luminal TLR ligands and more contact with endogenous ligands. This could be a factor affecting the TLR expression and signaling in SB-NETs and a possible reason why TLRs 1, 2, 4 and 6 did not seem to have prognostic significance in SB-NETs. Also, intrinsic ligand sensing TLRs could be hypothesized to have clinical relevance in non-luminal tumors, such as SB-NETs. In the present study, TLR7, recognizing intrinsic ligands, seemed to be prognostic in lymph node metastases, which are also not in direct contact of the bowel lumen. In esophageal adenocarcinoma, intrinsic factor sensing TLRs 3, 7 and 8 seemed to be upregulated in early events of esophageal carcinogenesis but had no association with prognosis, highlighting the tumor specific differences in TLR expression and clinical significance [<xref rid="pone.0302813.ref041" ref-type="bibr">41</xref>].</p>
      <p>The present study has potential clinical implications. TLR7 agonists and antagonists are available and could potentially be used in treatment of SB-NETs by either strengthening the antitumor effects of other treatment modalities or by direct antitumor effect. The study did not investigate TLR function, and because almost all TLRs were expressed in SB-NETs, TLRs could be tested as drug therapy targets despite most of them showing no association with survival in the present study.</p>
    </sec>
    <sec sec-type="conclusions" id="sec013">
      <title>Conclusions</title>
      <p>TLRs 1&#x2013;2 and 4&#x2013;9 are expressed in SB-NETs and SB-NET lymph node metastases. High TLR7 expression in lymph node metastases associates with worse disease specific survival. Due to large cohort size, the use of whole section slides and complete registry data, the results are strong, yet preliminary. To determine the future direction in this field of research, confirmatory studies with even larger cohorts and inclusion of G3/NEC disease are warranted&#x2013;especially regarding the observed survival association.</p>
    </sec>
    <sec id="sec014" sec-type="supplementary-material">
      <title>Supporting information</title>
      <supplementary-material id="pone.0302813.s001" position="float" content-type="local-data">
        <label>S1 Dataset</label>
        <caption>
          <title>Anonymized dataset of the statistical analyses.</title>
          <p>The data is in.sav format. IBM SPSS Statistics program is required to handle the data.</p>
          <p>(XLSX)</p>
        </caption>
        <media xlink:href="pone.0302813.s001.xlsx"/>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack>
      <p>Special thanks: Erja Tomperi, Tanja Kuusisto, Riitta Vuento, Sanna Mari Koskela, Harri Kaikkonen, Tuomas Moilanen, Tarja Piispanen and Biobank Borealis of Northern Finland for their excellent technical assistance.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="pone.0302813.ref001">
        <label>1</label>
        <mixed-citation publication-type="journal"><name><surname>Fernandez</surname><given-names>CJ</given-names></name>, <name><surname>Agarwal</surname><given-names>M</given-names></name>, <name><surname>Pottakkat</surname><given-names>B</given-names></name>, <name><surname>Haroon</surname><given-names>NN</given-names></name>, <name><surname>George</surname><given-names>AS</given-names></name>, <name><surname>Pappachan</surname><given-names>JM</given-names></name>. <article-title>Gastroenteropancreatic neuroendocrine neoplasms: A clinical snapshot.</article-title>
<source>World J Gastrointest Surg</source>. <year>2021</year>;<volume>13</volume>(<issue>3</issue>):<fpage>231</fpage>&#x2013;<lpage>255</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.4240/wjgs.v13.i3.231</pub-id>
<pub-id pub-id-type="pmid">33796213</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref002">
        <label>2</label>
        <mixed-citation publication-type="journal"><name><surname>Clift</surname><given-names>AK</given-names></name>, <name><surname>Kidd</surname><given-names>M</given-names></name>, <name><surname>Bodei</surname><given-names>L</given-names></name>, <name><surname>Toumpanakis</surname><given-names>C</given-names></name>, <name><surname>Baum</surname><given-names>RP</given-names></name>, <name><surname>Oberg</surname><given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Neuroendocrine Neoplasms of the Small Bowel and Pancreas</article-title>. <source>Neuroendocrinology</source>. <year>2020</year>;<volume>110</volume>(<issue>6</issue>):<fpage>444</fpage>&#x2013;<lpage>476</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1159/000503721</pub-id>
<pub-id pub-id-type="pmid">31557758</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref003">
        <label>3</label>
        <mixed-citation publication-type="journal"><name><surname>Dasari</surname><given-names>A</given-names></name>, <name><surname>Shen</surname><given-names>C</given-names></name>, <name><surname>Halperin</surname><given-names>D</given-names></name>, <name><surname>Zhao</surname><given-names>B</given-names></name>, <name><surname>Zhou</surname><given-names>S</given-names></name>, <name><surname>Xu</surname><given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States</article-title>. <source>JAMA Oncol</source>. <year>2017</year>;<volume>3</volume>(<issue>10</issue>):<fpage>1335</fpage>&#x2013;<lpage>1342</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1001/jamaoncol.2017.0589</pub-id>
<pub-id pub-id-type="pmid">28448665</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref004">
        <label>4</label>
        <mixed-citation publication-type="journal"><name><surname>Sackstein</surname><given-names>PE</given-names></name>, <name><surname>O&#x2019;Neil</surname><given-names>DS</given-names></name>, <name><surname>Neugut</surname><given-names>AI</given-names></name>, <name><surname>Chabot</surname><given-names>J</given-names></name>, <name><surname>Fojo</surname><given-names>T</given-names></name>. <article-title>Epidemiologic trends in neuroendocrine tumors: An examination of incidence rates and survival of specific patient subgroups over the past 20 years.</article-title>
<source>Semin Oncol</source>. <year>2018</year>;<volume>45</volume>(<issue>4</issue>):<fpage>249</fpage>&#x2013;<lpage>258</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1053/j.seminoncol.2018.07.001</pub-id>
<pub-id pub-id-type="pmid">30348533</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref005">
        <label>5</label>
        <mixed-citation publication-type="journal"><name><surname>Modlin</surname><given-names>IM</given-names></name>, <name><surname>Lye</surname><given-names>KD</given-names></name>, <name><surname>Kidd</surname><given-names>M</given-names></name>. <article-title>A 5-decade analysis of 13,715 carcinoid tumors</article-title>. <source>Cancer</source>. <year>2003</year>;<volume>97</volume>(<issue>4</issue>):<fpage>934</fpage>&#x2013;<lpage>959</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/cncr.11105</pub-id>
<pub-id pub-id-type="pmid">12569593</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref006">
        <label>6</label>
        <mixed-citation publication-type="journal"><name><surname>Yao</surname><given-names>JC</given-names></name>, <name><surname>Hassan</surname><given-names>M</given-names></name>, <name><surname>Phan</surname><given-names>A</given-names></name>, <name><surname>Dagohoy</surname><given-names>C</given-names></name>, <name><surname>Leary</surname><given-names>C</given-names></name>, <name><surname>Mares</surname><given-names>JE</given-names></name>, <etal>et al</etal>. <article-title>One hundred years after &#x201C;carcinoid&#x201D;: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.</article-title>
<source>J Clin Oncol</source>. <year>2008</year>;<volume>26</volume>(<issue>18</issue>):<fpage>3063</fpage>&#x2013;<lpage>3072</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1200/JCO.2007.15.4377</pub-id>
<pub-id pub-id-type="pmid">18565894</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref007">
        <label>7</label>
        <mixed-citation publication-type="journal"><name><surname>Takeda</surname><given-names>K</given-names></name>, <name><surname>Kaisho</surname><given-names>T</given-names></name>, <name><surname>Akira</surname><given-names>S</given-names></name>. <article-title>Toll-like Receptors.</article-title>
<source>Annu Rev Immunol</source>. <year>2003</year>;<volume>21</volume>:<fpage>335</fpage>&#x2013;<lpage>376</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1146/annurev.immunol.21.120601.141126</pub-id>
<pub-id pub-id-type="pmid">12524386</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref008">
        <label>8</label>
        <mixed-citation publication-type="journal"><name><surname>Testro</surname><given-names>AG</given-names></name>, <name><surname>Visvanathan</surname><given-names>K</given-names></name>. <article-title>Toll-like receptors and their role in gastrointestinal disease</article-title>. <source>J Gastroenterol Hepatol</source>. <year>2009</year>;<volume>24</volume>(<issue>6</issue>):<fpage>943</fpage>&#x2013;<lpage>954</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/j.1440-1746.2009.05854.x</pub-id>
<pub-id pub-id-type="pmid">19638078</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref009">
        <label>9</label>
        <mixed-citation publication-type="journal"><name><surname>Fitzgerald</surname><given-names>KA</given-names></name>, <name><surname>Kagan</surname><given-names>JC</given-names></name>. <article-title>Toll-like Receptors and the control of immunity</article-title>. <source>Cell</source>. <year>2020</year>;<volume>180</volume>(<issue>6</issue>):<fpage>1044</fpage>&#x2013;<lpage>1066</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.cell.2020.02.041</pub-id>
<pub-id pub-id-type="pmid">32164908</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref010">
        <label>10</label>
        <mixed-citation publication-type="journal"><name><surname>Takeuchi</surname><given-names>O</given-names></name>, <name><surname>Sato</surname><given-names>S</given-names></name>, <name><surname>Horiuchi</surname><given-names>T</given-names></name>, <name><surname>Hoshino</surname><given-names>K</given-names></name>, <name><surname>Takeda</surname><given-names>K</given-names></name>, <name><surname>Dong</surname><given-names>Z</given-names></name>, <etal>et al</etal>. <article-title>Cutting Edge: Role of Toll-Like Receptor 1 in Mediating Immune Response to Microbial Lipoproteins</article-title>. <source>J Immunol</source>. <year>2002</year>;<volume>169</volume>(<issue>1</issue>):<fpage>10</fpage>&#x2013;<lpage>14</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.4049/jimmunol.169.1.10</pub-id>
<pub-id pub-id-type="pmid">12077222</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref011">
        <label>11</label>
        <mixed-citation publication-type="journal"><name><surname>Takeuchi</surname><given-names>O</given-names></name>, <name><surname>Hoshino</surname><given-names>K</given-names></name>, <name><surname>Kawai</surname><given-names>T</given-names></name>, <name><surname>Sanjo</surname><given-names>H</given-names></name>, <name><surname>Takada</surname><given-names>H</given-names></name>, <name><surname>Ogawa</surname><given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components</article-title>. <source>Immunity</source>. <year>1999</year>;<volume>11</volume>(<issue>4</issue>):<fpage>443</fpage>&#x2013;<lpage>451</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/s1074-7613(00)80119-3</pub-id>
<pub-id pub-id-type="pmid">10549626</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref012">
        <label>12</label>
        <mixed-citation publication-type="journal"><name><surname>Alexopoulou</surname><given-names>L</given-names></name>, <name><surname>Holt</surname><given-names>A</given-names></name>, <name><surname>Medzhitov</surname><given-names>R</given-names></name>, <name><surname>Flavell</surname><given-names>R</given-names></name>. <article-title>Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3</article-title>. <source>Nature</source>. <year>2001</year>;<volume>413</volume>(<issue>6857</issue>):<fpage>732</fpage>&#x2013;<lpage>738</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/35099560</pub-id>
<pub-id pub-id-type="pmid">11607032</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref013">
        <label>13</label>
        <mixed-citation publication-type="journal"><name><surname>Poltorak</surname><given-names>A</given-names></name>, <name><surname>He</surname><given-names>X</given-names></name>, <name><surname>Smirnova</surname><given-names>I</given-names></name>, <name><surname>Liu</surname><given-names>MY</given-names></name>, <name><surname>Huffel</surname><given-names>C Van</given-names></name>, <name><surname>Du</surname><given-names>X</given-names></name>, <etal>et al</etal>. <article-title>Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4</article-title>
<source>Gene. Science</source>. <year>1998</year>;<volume>282</volume>(<issue>5396</issue>):<fpage>2085</fpage>&#x2013;<lpage>2088</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1126/science.282.5396.2085</pub-id>
<pub-id pub-id-type="pmid">9851930</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref014">
        <label>14</label>
        <mixed-citation publication-type="journal"><name><surname>Hayashi</surname><given-names>F</given-names></name>, <name><surname>Smith</surname><given-names>KD</given-names></name>, <name><surname>Ozinsky</surname><given-names>A</given-names></name>, <name><surname>Hawn</surname><given-names>TR</given-names></name>, <name><surname>Yi</surname><given-names>EC</given-names></name>, <name><surname>Goodlett</surname><given-names>DR</given-names></name>, <etal>et al</etal>. <article-title>The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5</article-title>. <source>Nature</source>. <year>2001</year>;<volume>410</volume>(<issue>6832</issue>):<fpage>1099</fpage>&#x2013;<lpage>1103</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/35074106</pub-id>
<pub-id pub-id-type="pmid">11323673</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref015">
        <label>15</label>
        <mixed-citation publication-type="journal"><name><surname>Takeuchi</surname><given-names>O</given-names></name>, <name><surname>Kawai</surname><given-names>T</given-names></name>, <name><surname>M&#xFC;hlradt</surname><given-names>PF</given-names></name>, <name><surname>Morr</surname><given-names>M</given-names></name>, <name><surname>Radolf</surname><given-names>JD</given-names></name>, <name><surname>Zychlinsky</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Discrimination of bacterial lipoproteins by Toll-like receptor 6</article-title>. <source>Int Immunol</source>. <year>2001</year>;<volume>13</volume>(<issue>7</issue>):<fpage>933</fpage>&#x2013;<lpage>940</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/intimm/13.7.933</pub-id>
<pub-id pub-id-type="pmid">11431423</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref016">
        <label>16</label>
        <mixed-citation publication-type="journal"><name><surname>Diebold</surname><given-names>SS</given-names></name>, <name><surname>Kaisho</surname><given-names>T</given-names></name>, <name><surname>Hemmi</surname><given-names>H</given-names></name>, <name><surname>Akira</surname><given-names>S</given-names></name>, <name><surname>Reis E Sousa</surname><given-names>C</given-names></name>. <article-title>Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA</article-title>. <source>Science</source>. <year>2004</year>;<volume>303</volume>(<issue>5663</issue>):<fpage>1529</fpage>&#x2013;<lpage>1531</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1126/science.1093616</pub-id>
<pub-id pub-id-type="pmid">14976261</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref017">
        <label>17</label>
        <mixed-citation publication-type="journal"><name><surname>Hemmi</surname><given-names>H</given-names></name>, <name><surname>Takeuchi</surname><given-names>O</given-names></name>, <name><surname>Kawai</surname><given-names>T</given-names></name>, <name><surname>Kaisho</surname><given-names>T</given-names></name>, <name><surname>Sato</surname><given-names>S</given-names></name>, <name><surname>Sanjo</surname><given-names>H</given-names></name>, <etal>et al</etal>. <article-title>A Toll-like receptor recognizes bacterial DNA</article-title>. <source>Nature</source>. <year>2000</year>;<volume>408</volume>(<issue>6813</issue>):<fpage>740</fpage>&#x2013;<lpage>745</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/35047123</pub-id>
<pub-id pub-id-type="pmid">11130078</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref018">
        <label>18</label>
        <mixed-citation publication-type="journal"><name><surname>De Nardo</surname><given-names>D.</given-names></name>
<article-title>Toll-like receptors: Activation, signalling and transcriptional modulation</article-title>. <source>Cytokine</source>. <year>2015</year>;<volume>74</volume>(<issue>2</issue>):<fpage>181</fpage>&#x2013;<lpage>189</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.cyto.2015.02.025</pub-id>
<pub-id pub-id-type="pmid">25846205</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref019">
        <label>19</label>
        <mixed-citation publication-type="journal"><name><surname>Su</surname><given-names>SB</given-names></name>, <name><surname>Tao</surname><given-names>L</given-names></name>, <name><surname>Deng</surname><given-names>ZP</given-names></name>, <name><surname>Chen</surname><given-names>W</given-names></name>, <name><surname>Qin</surname><given-names>SY</given-names></name>, <name><surname>Jiang</surname><given-names>HX</given-names></name>. <article-title>TLR10: Insights, controversies and potential utility as a therapeutic target</article-title>. <source>Scand J Immunol</source>. <year>2021</year>;<volume>93</volume>(<issue>4</issue>):<fpage>e12988</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/sji.12988</pub-id>
<pub-id pub-id-type="pmid">33047375</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref020">
        <label>20</label>
        <mixed-citation publication-type="journal"><name><surname>Jin Jo</surname><given-names>H</given-names></name>, <name><surname>Kim</surname><given-names>J</given-names></name>, <name><surname>Kim</surname><given-names>N</given-names></name>, <name><surname>Hyun Park</surname><given-names>J</given-names></name>, <name><surname>Hee Nam</surname><given-names>R</given-names></name>, <name><surname>Seok</surname><given-names>YJ</given-names></name>, <etal>et al</etal>. <article-title>Analysis of Gastric Microbiota by Pyrosequencing: Minor Role of Bacteria Other Than Helicobacter pylori in the Gastric Carcinogenesis</article-title>. <source>Helicobacter</source>. <year>2016</year>;<volume>21</volume>(<issue>5</issue>):<fpage>364</fpage>&#x2013;<lpage>374</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/hel.12293</pub-id>
<pub-id pub-id-type="pmid">26915731</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref021">
        <label>21</label>
        <mixed-citation publication-type="journal"><name><surname>Mazzanti</surname><given-names>R.</given-names></name>
<article-title>Hepatocellular carcinoma: Where are we</article-title>? <source>World J Exp Med</source>. <year>2016</year>;<volume>6</volume>(<issue>1</issue>):<fpage>21</fpage>&#x2013;<lpage>36</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.5493/wjem.v6.i1.21</pub-id>
<pub-id pub-id-type="pmid">26929917</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref022">
        <label>22</label>
        <mixed-citation publication-type="journal"><name><surname>Yu</surname><given-names>L</given-names></name>, <name><surname>Wang</surname><given-names>L</given-names></name>, <name><surname>Chen</surname><given-names>S</given-names></name>. <article-title>Exogenous or endogenous toll-like receptor ligands: Which is the MVP in tumorigenesis</article-title>? <source>Cell Mol Life Sci</source>. <year>2012</year>;<volume>69</volume>(<issue>6</issue>):<fpage>935</fpage>&#x2013;<lpage>949</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s00018-011-0864-6</pub-id>
<pub-id pub-id-type="pmid">22048194</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref023">
        <label>23</label>
        <mixed-citation publication-type="journal"><name><surname>Dajon</surname><given-names>M</given-names></name>, <name><surname>Iribarren</surname><given-names>K</given-names></name>, <name><surname>Cremer</surname><given-names>I</given-names></name>. <article-title>Toll-like receptor stimulation in cancer: A pro-and anti-tumor double-edged sword</article-title>. <source>Immunobiology</source>. <year>2017</year>;<volume>222</volume>(<issue>1</issue>):<fpage>89</fpage>&#x2013;<lpage>100</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.imbio.2016.06.009</pub-id>
<pub-id pub-id-type="pmid">27349597</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref024">
        <label>24</label>
        <mixed-citation publication-type="journal"><name><surname>Hiltunen</surname><given-names>N</given-names></name>, <name><surname>V&#xE4;yrynen</surname><given-names>JP</given-names></name>, <name><surname>B&#xF6;hm</surname><given-names>J</given-names></name>, <name><surname>Helminen</surname><given-names>O</given-names></name>. <article-title>CD3+, CD8+, CD4+ and FOXP3+ T Cells in the Immune Microenvironment of Small Bowel Neuroendocrine Tumors.</article-title>
<source>Diseases</source>. <year>2021</year>;<volume>9</volume>(<issue>2</issue>):<fpage>42</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/diseases9020042</pub-id>
<pub-id pub-id-type="pmid">34208144</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref025">
        <label>25</label>
        <mixed-citation publication-type="book"><name><surname>Woltering</surname><given-names>E</given-names></name>, <etal>et al</etal>. <part-title>AJCC Cancer Staging Manual.</part-title>
<edition designator="8">8th ed</edition>. <name><surname>Amin</surname><given-names>M</given-names></name>, <etal>et al</etal>., editors. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Springer</publisher-name>; <year>2017</year>. 375&#x2013;387 p.</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref026">
        <label>26</label>
        <mixed-citation publication-type="journal"><name><surname>Nagtegaal</surname><given-names>ID</given-names></name>, <name><surname>Odze</surname><given-names>RD</given-names></name>, <name><surname>Klimstra</surname><given-names>D</given-names></name>, <name><surname>Paradis</surname><given-names>V</given-names></name>, <name><surname>Rugge</surname><given-names>M</given-names></name>, <name><surname>Schirmacher</surname><given-names>P</given-names></name>, <etal>et al</etal>. <article-title>The 2019 WHO classification of tumours of the digestive system.</article-title>
<source>Histopathology.</source>
<year>2020</year>;<volume>76</volume>(<issue>2</issue>):<fpage>182</fpage>&#x2013;<lpage>188</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/his.13975</pub-id>
<pub-id pub-id-type="pmid">31433515</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref027">
        <label>27</label>
        <mixed-citation publication-type="journal"><name><surname>Bankhead</surname><given-names>P</given-names></name>, <name><surname>Loughrey</surname><given-names>MB</given-names></name>, <name><surname>Fern&#xE1;ndez</surname><given-names>JA</given-names></name>, <name><surname>Dombrowski</surname><given-names>Y</given-names></name>, <name><surname>McArt</surname><given-names>DG</given-names></name>, <name><surname>Dunne</surname><given-names>PD</given-names></name>, <etal>et al</etal>. <article-title>QuPath: Open source software for digital pathology image analysis.</article-title>
<source>Sci Rep.</source>
<year>2017</year>;<volume>7</volume>(<issue>1</issue>). <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41598-017-17204-5</pub-id>
<pub-id pub-id-type="pmid">29203879</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref028">
        <label>28</label>
        <mixed-citation publication-type="journal"><name><surname>Jouhi</surname><given-names>L</given-names></name>, <name><surname>Koljonen</surname><given-names>V</given-names></name>, <name><surname>B&#xF6;hling</surname><given-names>T</given-names></name>, <name><surname>Haglund</surname><given-names>C</given-names></name>, <name><surname>Hagstr&#xF6;m</surname><given-names>J</given-names></name>. <article-title>The Expression of Toll-like Receptors 2, 4, 5, 7 and 9 in Merkel Cell Carcinoma</article-title>. <source>Anticancer Res</source>. <year>2015</year>;<volume>35</volume>(<issue>4</issue>):<fpage>1843</fpage>&#x2013;<lpage>1849</lpage>. <pub-id pub-id-type="pmid">25862837</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref029">
        <label>29</label>
        <mixed-citation publication-type="journal"><name><surname>Imon</surname><given-names>RR</given-names></name>, <name><surname>Samad</surname><given-names>A</given-names></name>, <name><surname>Alam</surname><given-names>R</given-names></name>, <name><surname>Alsaiari</surname><given-names>AA</given-names></name>, <name><surname>Talukder</surname><given-names>MEK</given-names></name>, <name><surname>Almehmadi</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Computational formulation of a multiepitope vaccine unveils an exceptional prophylactic candidate against Merkel cell polyomavirus</article-title>. <source>Front Immunol</source>. <year>2023</year>;<volume>14</volume>:<fpage>1</fpage>&#x2013;<lpage>20</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3389/fimmu.2023.1160260</pub-id>
<pub-id pub-id-type="pmid">37441076</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref030">
        <label>30</label>
        <mixed-citation publication-type="journal"><name><surname>Bhatia</surname><given-names>S</given-names></name>, <name><surname>Miller</surname><given-names>NJ</given-names></name>, <name><surname>Lu</surname><given-names>H</given-names></name>, <name><surname>Vandeven</surname><given-names>N</given-names></name>, <name><surname>Ibrani</surname><given-names>D</given-names></name>, <name><surname>Shinohara</surname><given-names>MM</given-names></name>, <etal>et al</etal>. <article-title>Intratumoral G100, a TLR4 agonist, induces anti-tumor immune responses and tumor regression in patients with Merkel cell carcinoma</article-title>. <source>Clin Cancer Res</source>. <year>2019</year>;<volume>25</volume>(<issue>4</issue>):<fpage>1185</fpage>&#x2013;<lpage>1195</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-18-0469</pub-id>
<pub-id pub-id-type="pmid">30093453</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref031">
        <label>31</label>
        <mixed-citation publication-type="journal"><name><surname>Young</surname><given-names>K</given-names></name>, <name><surname>Lawlor</surname><given-names>RT</given-names></name>, <name><surname>Ragulan</surname><given-names>C</given-names></name>, <name><surname>Patil</surname><given-names>Y</given-names></name>, <name><surname>Mafficini</surname><given-names>A</given-names></name>, <name><surname>Bersani</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours.</article-title>
<source>Gut.</source>
<year>2021</year>;<volume>70</volume>(<issue>10</issue>):<fpage>1904</fpage>&#x2013;<lpage>1913</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/gutjnl-2020-321016</pub-id>
<pub-id pub-id-type="pmid">32883872</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref032">
        <label>32</label>
        <mixed-citation publication-type="journal"><name><surname>&#xC7;elik</surname><given-names>ZE</given-names></name>, <name><surname>Demir</surname><given-names>F</given-names></name>, <name><surname>Yonar</surname><given-names>H</given-names></name>, <name><surname>&#xC7;elik</surname><given-names>M</given-names></name>, <name><surname>Eren</surname><given-names>O&#xD6;</given-names></name>. <article-title>Association of Toll-Like Receptor 9 Expression With Prognosis in Breast Carcinoma.</article-title>
<source>J Contemp Med.</source>
<year>2023</year>;<volume>13</volume>(<issue>4</issue>):<fpage>676</fpage>&#x2013;<lpage>681</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.16899/jcm.1315131</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0302813.ref033">
        <label>33</label>
        <mixed-citation publication-type="journal"><name><surname>Cherfils-Vicini</surname><given-names>J</given-names></name>, <name><surname>Platonova</surname><given-names>S</given-names></name>, <name><surname>Gillard</surname><given-names>M</given-names></name>, <name><surname>Laurans</surname><given-names>L</given-names></name>, <name><surname>Validire</surname><given-names>P</given-names></name>, <name><surname>Caliandro</surname><given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance</article-title>. <source>J Clin Invest</source>. <year>2010</year>;<volume>120</volume>(<issue>4</issue>):<fpage>1285</fpage>&#x2013;<lpage>1297</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1172/JCI36551</pub-id>
<pub-id pub-id-type="pmid">20237413</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref034">
        <label>34</label>
        <mixed-citation publication-type="journal"><name><surname>Chandrasekar</surname><given-names>SA</given-names></name>, <name><surname>Palaniyandi</surname><given-names>T</given-names></name>, <name><surname>Parthasarathy</surname><given-names>U</given-names></name>, <name><surname>Surendran</surname><given-names>H</given-names></name>, <name><surname>Viswanathan</surname><given-names>S</given-names></name>, <name><surname>Wahab</surname><given-names>MRA</given-names></name>, <etal>et al</etal>. <article-title>Implications of Toll-like receptors (TLRs) and their signaling mechanisms in human cancers.</article-title>
<source>Pathol Res Pract.</source>
<year>2023</year>;<volume>248</volume>:<fpage>154673</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.prp.2023.154673</pub-id>
<pub-id pub-id-type="pmid">37453359</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref035">
        <label>35</label>
        <mixed-citation publication-type="journal"><name><surname>Sheyhidin</surname><given-names>I</given-names></name>, <name><surname>Nabi</surname><given-names>G</given-names></name>, <name><surname>Hasim</surname><given-names>A</given-names></name>, <name><surname>Zhang</surname><given-names>RP</given-names></name>, <name><surname>Ainiwaer</surname><given-names>J</given-names></name>, <name><surname>Ma</surname><given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma</article-title>. <source>World J Gastroenterol</source>. <year>2011</year>;<volume>17</volume>(<issue>32</issue>):<fpage>3745</fpage>&#x2013;<lpage>3751</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3748/wjg.v17.i32.3745</pub-id>
<pub-id pub-id-type="pmid">21990957</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref036">
        <label>36</label>
        <mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>Z</given-names></name>, <name><surname>Xie</surname><given-names>Y</given-names></name>, <name><surname>Xiong</surname><given-names>Y</given-names></name>, <name><surname>Liu</surname><given-names>S</given-names></name>, <name><surname>Qiu</surname><given-names>C</given-names></name>, <name><surname>Zhu</surname><given-names>Z</given-names></name>, <etal>et al</etal>. <article-title>TLR 7/8 agonist reverses oxaliplatin resistance in colorectal cancer via directing the myeloid-derived suppressor cells to tumoricidal M1-macrophages</article-title>. <source>Cancer Lett</source>. <year>2020</year>;<volume>469</volume>:<fpage>173</fpage>&#x2013;<lpage>185</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.canlet.2019.10.020</pub-id>
<pub-id pub-id-type="pmid">31629935</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref037">
        <label>37</label>
        <mixed-citation publication-type="journal"><name><surname>Ye</surname><given-names>J</given-names></name>, <name><surname>Mills</surname><given-names>BN</given-names></name>, <name><surname>Qin</surname><given-names>SS</given-names></name>, <name><surname>Garrett-Larsen</surname><given-names>J</given-names></name>, <name><surname>Murphy</surname><given-names>JD</given-names></name>, <name><surname>Uccello</surname><given-names>TP</given-names></name>, <etal>et al</etal>. <article-title>Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancer</article-title>. <source>J Immunother Cancer</source>. <year>2022</year>;<volume>10</volume>(<issue>7</issue>):<fpage>e004784</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/jitc-2022-004784</pub-id>
<pub-id pub-id-type="pmid">35851308</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref038">
        <label>38</label>
        <mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>Q</given-names></name>, <name><surname>Zhang</surname><given-names>X</given-names></name>, <name><surname>Xiao</surname><given-names>T</given-names></name>, <name><surname>Pan</surname><given-names>C</given-names></name>, <name><surname>Liu</surname><given-names>X</given-names></name>, <name><surname>Zhao</surname><given-names>Y</given-names></name>. <article-title>Prognostic role of Toll-like receptors in cancer: A meta-analysis</article-title>. <source>Ther Clin Risk Manag</source>. <year>2018</year>;<volume>14</volume>:<fpage>1323</fpage>&#x2013;<lpage>1330</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2147/TCRM.S171341</pub-id>
<pub-id pub-id-type="pmid">30104878</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref039">
        <label>39</label>
        <mixed-citation publication-type="journal"><name><surname>Sun</surname><given-names>H</given-names></name>, <name><surname>Li</surname><given-names>Y</given-names></name>, <name><surname>Zhang</surname><given-names>P</given-names></name>, <name><surname>Xing</surname><given-names>H</given-names></name>, <name><surname>Zhao</surname><given-names>S</given-names></name>, <name><surname>Song</surname><given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives.</article-title>
<source>Biomark Res</source>. <year>2022</year>;<volume>10</volume>(<issue>1</issue>):<fpage>89</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s40364-022-00436-7</pub-id>
<pub-id pub-id-type="pmid">36476317</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref040">
        <label>40</label>
        <mixed-citation publication-type="journal"><name><surname>Huhta</surname><given-names>H</given-names></name>, <name><surname>Helminen</surname><given-names>O</given-names></name>, <name><surname>Lehenkari</surname><given-names>PP</given-names></name>, <name><surname>Saarnio</surname><given-names>J</given-names></name>, <name><surname>Karttunen</surname><given-names>TJ</given-names></name>, <name><surname>Kauppila</surname><given-names>JH</given-names></name>. <article-title>Toll-like receptors 1, 2, 4 and 6 in esophageal epithelium, Barrett&#x2019;s esophagus, dysplasia and adenocarcinoma.</article-title>
<source>Oncotarget</source>. <year>2016</year>;<volume>7</volume>(<issue>17</issue>):<fpage>23658</fpage>&#x2013;<lpage>23667</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.18632/oncotarget.8151</pub-id>
<pub-id pub-id-type="pmid">27008696</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302813.ref041">
        <label>41</label>
        <mixed-citation publication-type="journal"><name><surname>Helminen</surname><given-names>O</given-names></name>, <name><surname>Huhta</surname><given-names>H</given-names></name>, <name><surname>Lehenkari</surname><given-names>PP</given-names></name>, <name><surname>Saarnio</surname><given-names>J</given-names></name>, <name><surname>Karttunen</surname><given-names>TJ</given-names></name>, <name><surname>Kauppila</surname><given-names>JH</given-names></name>. <article-title>Nucleic acid-sensing toll-like receptors 3, 7 and 8 in esophageal epithelium, barrett&#x2019;s esophagus, dysplasia and adenocarcinoma.</article-title>
<source>Oncoimmunology.</source>
<year>2016</year>;<volume>5</volume>(<issue>5</issue>):<fpage>e1127495</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1080/2162402X.2015.1127495</pub-id>
<pub-id pub-id-type="pmid">27467941</pub-id>
</mixed-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="aggregated-review-documents" id="pone.0302813.r001" specific-use="decision-letter">
    <front-stub>
      <article-id pub-id-type="doi">10.1371/journal.pone.0302813.r001</article-id>
      <title-group>
        <article-title>Decision Letter 0</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Ullah</surname>
            <given-names>Mohsan</given-names>
          </name>
          <role>Academic Editor</role>
        </contrib>
      </contrib-group>
      <permissions>
        <copyright-statement>&#xA9; 2024 Mohsan Ullah</copyright-statement>
        <copyright-year>2024</copyright-year>
        <copyright-holder>Mohsan Ullah</copyright-holder>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0302813" id="rel-obj001" related-article-type="reviewed-article"/>
      <custom-meta-group>
        <custom-meta>
          <meta-name>Submission Version</meta-name>
          <meta-value>0</meta-value>
        </custom-meta>
      </custom-meta-group>
    </front-stub>
    <body>
      <p>
<named-content content-type="letter-date">20 Dec 2023</named-content>
</p>
      <p><!-- <div> -->PONE-D-23-35599<!-- </div> --><!-- <div> -->Toll-like receptors 1&#x2013;9&#xA0;in small bowel neuroendocrine tumors &#x2013;&#xA0;Clinical significance and prognosis<!-- </div> --><!-- <div> -->PLOS ONE</p>
      <p>Dear Dr. Hiltunen,</p>
      <p>Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE&#x2019;s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.</p>
      <p>
<bold>After careful evaluation of the reviewer&#x2019;s comments, it has been decided that your manuscript requires major revisions before it can be considered for publication. I want to emphasize that this choice is not a reflection of the caliber of your work overall; rather, it is a measure to make sure the manuscript satisfies the high standards of excellence that our journal demands.</bold>
<!-- </div> -->
<!-- <div> -->
</p>
      <p>Please submit your revised manuscript by Feb 03 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at&#xA0;<email>plosone@plos.org</email>. When you're ready to submit your revision, log on to <ext-link xlink:href="https://www.editorialmanager.com/pone/" ext-link-type="uri">https://www.editorialmanager.com/pone/</ext-link> and select the 'Submissions Needing Revision' folder to locate your manuscript file.</p>
      <p>Please include the following items when submitting your revised manuscript:<!-- </div> --><list list-type="bullet"><list-item><p>A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.</p></list-item><list-item><p>A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.</p></list-item><list-item><p>An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.</p></list-item></list></p>
      <p>If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.</p>
      <p>If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <ext-link xlink:href="https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols" ext-link-type="uri">https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols</ext-link>. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at <ext-link xlink:href="https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols" ext-link-type="uri">https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols</ext-link>.</p>
      <p>We look forward to receiving your revised manuscript.</p>
      <p>Kind regards,</p>
      <p>Mohsan Ullah</p>
      <p>Academic Editor</p>
      <p>PLOS ONE</p>
      <p>Journal Requirements:</p>
      <p>1. When submitting your revision, we need you to address these additional requirements.</p>
      <p>Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at&#xA0;</p>
      <p><ext-link xlink:href="https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf" ext-link-type="uri">https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf</ext-link> and&#xA0;</p>
      <p>
<ext-link xlink:href="https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf" ext-link-type="uri">https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf</ext-link>
</p>
      <p>2. We note that the grant information you provided in the &#x2018;Funding Information&#x2019; and &#x2018;Financial Disclosure&#x2019; sections do not match.&#xA0;</p>
      <p>When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the &#x2018;Funding Information&#x2019; section.</p>
      <p>Additional Editor Comments:</p>
      <p>Following the careful consideration of reviewers comments, I encourage authors to revise the reviewers concerns and submit the revised manuscript.</p>
      <p>[Note: HTML markup is below. Please do not edit.]</p>
      <p>Reviewers' comments:</p>
      <p>Reviewer's Responses to Questions</p>
      <p>
<!-- <font color="black"> -->
<bold>Comments to the Author</bold>
</p>
      <p>1. Is the manuscript technically sound, and do the data support the conclusions?</p>
      <p>The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. <!-- </font> --></p>
      <p>Reviewer #1:&#xA0;No</p>
      <p>Reviewer #2:&#xA0;Yes</p>
      <p>**********</p>
      <p><!-- <font color="black"> -->2. Has the statistical analysis been performed appropriately and rigorously? <!-- </font> --></p>
      <p>Reviewer #1:&#xA0;Yes</p>
      <p>Reviewer #2:&#xA0;Yes</p>
      <p>**********</p>
      <p><!-- <font color="black"> -->3. Have the authors made all data underlying the findings in their manuscript fully available?</p>
      <p>The <ext-link xlink:href="http://www.plosone.org/static/policies.action#sharing" ext-link-type="uri">PLOS Data policy</ext-link> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data&#x2014;e.g. participant privacy or use of data from a third party&#x2014;those must be specified.<!-- </font> --></p>
      <p>Reviewer #1:&#xA0;Yes</p>
      <p>Reviewer #2:&#xA0;No</p>
      <p>**********</p>
      <p><!-- <font color="black"> -->4. Is the manuscript presented in an intelligible fashion and written in standard English?</p>
      <p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.<!-- </font> --></p>
      <p>Reviewer #1:&#xA0;Yes</p>
      <p>Reviewer #2:&#xA0;Yes</p>
      <p>**********</p>
      <p><!-- <font color="black"> -->5. Review Comments to the Author</p>
      <p>Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)<!-- </font> --></p>
      <p>Reviewer #1:&#xA0;Dear authors</p>
      <p>The study has significant scientific importance and has interesting findings. Methods and sample size is suitable and sufficient. The discussion section can be improved using recent studies from 2022 and 2023. I is acceptable in the present form.</p>
      <p>Kind regards</p>
      <p>Reviewer #2:&#xA0;The manuscript (PONE-D-23-35599) entitled Toll-like receptors 1&#x2013;9 in small bowel neuroendocrine tumors &#x2013; Clinical significance and prognosis' has been carefully reviewed as per the guidelines of the journal. In my point of view, the manuscript is judged to be of potential interest to the readers and the scientific community as well. While the overall concept of the paper is reasonably satisfactory, it falls within the scope of the journal. However, it has some corrections. The manuscript still has a number of flaws, which need to be addressed before it is formally accepted for publication. For instance, there are some errors in the manuscript's scientific, typographical, and grammatical content. Overall, this manuscript may offer important contributions to the literature, but needs some minor corrections for possible publication in this journal</p>
      <p>**********</p>
      <p><!-- <font color="black"> -->6. PLOS authors have the option to publish the peer review history of their article (<ext-link xlink:href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" ext-link-type="uri">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p>
      <p>If you choose &#x201C;no&#x201D;, your identity will remain anonymous but your review may still be made public.</p>
      <p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link xlink:href="https://www.plos.org/privacy-policy" ext-link-type="uri">Privacy Policy</ext-link>.<!-- </font> --></p>
      <p>Reviewer #1:&#xA0;No</p>
      <p>Reviewer #2:&#xA0;No</p>
      <p>**********</p>
      <p>[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]</p>
      <p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool,&#xA0;<ext-link xlink:href="https://pacev2.apexcovantage.com/" ext-link-type="uri">https://pacev2.apexcovantage.com/</ext-link>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at&#xA0;<email>figures@plos.org</email>. Please note that Supporting Information files do not need this step.</p>
      <supplementary-material id="pone.0302813.s002" position="float" content-type="local-data">
        <label>Attachment</label>
        <caption>
          <p>Submitted filename: <named-content content-type="submitted-filename">(PONE-D-23-35599) Review comments.docx</named-content></p>
        </caption>
        <media xlink:href="pone.0302813.s002.docx"/>
      </supplementary-material>
    </body>
  </sub-article>
  <sub-article article-type="author-comment" id="pone.0302813.r002">
    <front-stub>
      <article-id pub-id-type="doi">10.1371/journal.pone.0302813.r002</article-id>
      <title-group>
        <article-title>Author response to Decision Letter 0</article-title>
      </title-group>
      <related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0302813" id="rel-obj002" related-article-type="editor-report"/>
      <custom-meta-group>
        <custom-meta>
          <meta-name>Submission Version</meta-name>
          <meta-value>1</meta-value>
        </custom-meta>
      </custom-meta-group>
    </front-stub>
    <body>
      <p>
<named-content content-type="author-response-date">1 Feb 2024</named-content>
</p>
      <p>Responses are listed in a separate file labelled "Response to Reviewers".</p>
      <supplementary-material id="pone.0302813.s003" position="float" content-type="local-data">
        <label>Attachment</label>
        <caption>
          <p>Submitted filename: <named-content content-type="submitted-filename">Response to Reviewers.docx</named-content></p>
        </caption>
        <media xlink:href="pone.0302813.s003.docx"/>
      </supplementary-material>
    </body>
  </sub-article>
  <sub-article article-type="aggregated-review-documents" id="pone.0302813.r003" specific-use="decision-letter">
    <front-stub>
      <article-id pub-id-type="doi">10.1371/journal.pone.0302813.r003</article-id>
      <title-group>
        <article-title>Decision Letter 1</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Luwen</given-names>
          </name>
          <role>Academic Editor</role>
        </contrib>
      </contrib-group>
      <permissions>
        <copyright-statement>&#xA9; 2024 Luwen Zhang</copyright-statement>
        <copyright-year>2024</copyright-year>
        <copyright-holder>Luwen Zhang</copyright-holder>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0302813" id="rel-obj003" related-article-type="reviewed-article"/>
      <custom-meta-group>
        <custom-meta>
          <meta-name>Submission Version</meta-name>
          <meta-value>1</meta-value>
        </custom-meta>
      </custom-meta-group>
    </front-stub>
    <body>
      <p>
<named-content content-type="letter-date">15 Apr 2024</named-content>
</p>
      <p>Toll-like receptors 1&#x2013;9&#xA0;in small bowel neuroendocrine tumors &#x2013;&#xA0;Clinical significance and prognosis</p>
      <p>PONE-D-23-35599R1</p>
      <p>Dear Dr. Hiltunen,</p>
      <p>We&#x2019;re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.</p>
      <p>Within one week, you&#x2019;ll receive an e-mail detailing the required amendments. When these have been addressed, you&#x2019;ll receive a formal acceptance letter and your manuscript will be scheduled for publication.</p>
      <p>An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at <ext-link xlink:href="https://www.editorialmanager.com/pone/" ext-link-type="uri">Editorial Manager&#xAE;</ext-link>&#xA0;and clicking the &#x2018;Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at <email>authorbilling@plos.org</email>.</p>
      <p>If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they&#x2019;ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <email>onepress@plos.org</email>.</p>
      <p>Kind regards,</p>
      <p>Luwen Zhang</p>
      <p>Academic Editor</p>
      <p>PLOS ONE</p>
      <p>Additional Editor Comments (optional):</p>
      <p>Reviewers' comments:</p>
      <p>Reviewer's Responses to Questions</p>
      <p>
<!-- <font color="black"> -->
<bold>Comments to the Author</bold>
</p>
      <p>1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the &#x201C;Comments to the Author&#x201D; section, enter your conflict of interest statement in the &#x201C;Confidential to Editor&#x201D; section, and submit your "Accept" recommendation.<!-- </font> --></p>
      <p>Reviewer #1:&#xA0;(No Response)</p>
      <p>Reviewer #2:&#xA0;All comments have been addressed</p>
      <p>**********</p>
      <p><!-- <font color="black"> -->2. Is the manuscript technically sound, and do the data support the conclusions?</p>
      <p>The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. <!-- </font> --></p>
      <p>Reviewer #1:&#xA0;(No Response)</p>
      <p>Reviewer #2:&#xA0;Yes</p>
      <p>**********</p>
      <p><!-- <font color="black"> -->3. Has the statistical analysis been performed appropriately and rigorously? <!-- </font> --></p>
      <p>Reviewer #1:&#xA0;(No Response)</p>
      <p>Reviewer #2:&#xA0;Yes</p>
      <p>**********</p>
      <p><!-- <font color="black"> -->4. Have the authors made all data underlying the findings in their manuscript fully available?</p>
      <p>The <ext-link xlink:href="http://www.plosone.org/static/policies.action#sharing" ext-link-type="uri">PLOS Data policy</ext-link> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data&#x2014;e.g. participant privacy or use of data from a third party&#x2014;those must be specified.<!-- </font> --></p>
      <p>Reviewer #1:&#xA0;(No Response)</p>
      <p>Reviewer #2:&#xA0;Yes</p>
      <p>**********</p>
      <p><!-- <font color="black"> -->5. Is the manuscript presented in an intelligible fashion and written in standard English?</p>
      <p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.<!-- </font> --></p>
      <p>Reviewer #1:&#xA0;(No Response)</p>
      <p>Reviewer #2:&#xA0;Yes</p>
      <p>**********</p>
      <p><!-- <font color="black"> -->6. Review Comments to the Author</p>
      <p>Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)<!-- </font> --></p>
      <p>Reviewer #1:&#xA0;(No Response)</p>
      <p>Reviewer #2:&#xA0;(No Response)</p>
      <p>**********</p>
      <p><!-- <font color="black"> -->7. PLOS authors have the option to publish the peer review history of their article (<ext-link xlink:href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" ext-link-type="uri">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p>
      <p>If you choose &#x201C;no&#x201D;, your identity will remain anonymous but your review may still be made public.</p>
      <p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link xlink:href="https://www.plos.org/privacy-policy" ext-link-type="uri">Privacy Policy</ext-link>.<!-- </font> --></p>
      <p>Reviewer #1:&#xA0;No</p>
      <p>Reviewer #2:&#xA0;No</p>
      <p>**********</p>
      <supplementary-material id="pone.0302813.s004" position="float" content-type="local-data">
        <label>Attachment</label>
        <caption>
          <p>Submitted filename: <named-content content-type="submitted-filename">Reviewer Comments.docx</named-content></p>
        </caption>
        <media xlink:href="pone.0302813.s004.docx"/>
      </supplementary-material>
    </body>
  </sub-article>
  <sub-article article-type="editor-report" id="pone.0302813.r004" specific-use="acceptance-letter">
    <front-stub>
      <article-id pub-id-type="doi">10.1371/journal.pone.0302813.r004</article-id>
      <title-group>
        <article-title>Acceptance letter</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Luwen</given-names>
          </name>
          <role>Academic Editor</role>
        </contrib>
      </contrib-group>
      <permissions>
        <copyright-statement>&#xA9; 2024 Luwen Zhang</copyright-statement>
        <copyright-year>2024</copyright-year>
        <copyright-holder>Luwen Zhang</copyright-holder>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0302813" id="rel-obj004" related-article-type="reviewed-article"/>
    </front-stub>
    <body>
      <p>
<named-content content-type="letter-date">26 Apr 2024</named-content>
</p>
      <p>PONE-D-23-35599R1 </p>
      <p>PLOS ONE</p>
      <p>Dear Dr. Hiltunen, </p>
      <p>I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.</p>
      <p>At this stage, our production department will prepare your paper for publication. This includes ensuring the following:</p>
      <p>* All references, tables, and figures are properly cited</p>
      <p>* All relevant supporting information is included in the manuscript submission,</p>
      <p>* There are no issues that prevent the paper from being properly typeset</p>
      <p>If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. </p>
      <p>Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <email>onepress@plos.org</email>.</p>
      <p>If we can help with anything else, please email us at <email>customercare@plos.org</email>.</p>
      <p>Thank you for submitting your work to PLOS ONE and supporting open access. </p>
      <p>Kind regards, </p>
      <p>PLOS ONE Editorial Office Staff</p>
      <p>on behalf of</p>
      <p>Dr Luwen Zhang </p>
      <p>Academic Editor</p>
      <p>PLOS ONE</p>
    </body>
  </sub-article>
</article>
</pmc-articleset>